Accessibility statement

CHE Staff publications archive

Staff in CHE publish frequently, including contributing to journals, books and commissioned reports. Archived publications are listed by year.

2015

2015

  • Abongomera G, Kiwuwa-Muyingo S, Revill P et al, for the Lablite Project Team. Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda. BMC Health Services Research 2015;15:527. Download from biomedcentral
  • Alfonso Ross Terres J, Lozano-Ortega G, Kendall R, Sculpher M. Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). BMC Cardiovascular Disorders 2015;15:180. Download from Springer 
  • Asaria M, Griffin S, Cookson R et al. Distributional cost-effectiveness analysis of health care programmes – a methodological case study of the UK bowel cancer screening programme. Health Economics 2015;24(6):742-754. Download from Wiley
  • Ball K, Lamb KE, Costa C, et al, Santos R, et al. Neighbourhood socioeconomic disadvantage and fruit and vegetable consumption: a seven countries comparison. International Journal of Behavioral Nutrition and Physical Activity 2015;12:68. Download from ijbnpa
  • Ballard SB, Saito M, Mirelman AJ, et al. Tropical and travel-associated norovirus: current concepts. Current Opinion in Infectious Diseases 2015;28(5):408-416.
  • Barber S, Akhtar S, Jackson C, Bingham D, Hewitt C, Routen A, Richardson G, et al. Preschoolers in the Playground: a pilot cluster randomised controlled trial of a physical activity intervention for children aged 18 months to 4 years. Public Health Research 2015;3(5). Download from NIHR
  • Barnabus RV, Bendavid E, et al, Revill P, et al. Priorities for HIV Care in sub-Saharan Africa: a Population Perspective, HIV Modelling Consortium. Report for the World Health Organization HIV Treatment Guidelines Development Committee 2015. Download from HIV modelling
  • Bartoll X, Toffolutti V, Malmusi D, Palència L, Borrell C, Suhrcke M. Health and health behaviours before and during the Great Recession, overall and by socioeconomic status, using data from four repeated cross-sectional Health Surveys in Spain (2001-2012). BMC Public Health 2015;15:865. Download from BioMed 
  • Bubela T, McCabe C, et al, Soares M, et al. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. Regenerative Medicine 2015;10(7):897–911. Download from Futuremedicine
  • Cambiano V, Ford D, et al, Revill P, Phillips A. Assessment of the potential impact and cost-effectiveness of self-testing for HIV in low-income countries. The Journal of Infectious Diseases 2015;212(4):570-577. Download from Oxford journals
  • Campbell JD, McQueen RB, Libby AM, Spackman E, et al. Cost-effectiveness uncertainty analysis methods: A comparison of one-way sensitivity, analysis of covariance, and expected value of partial perfect information. Medical Decision Making 2015;35(5):596-607. Download from Sage
  • Cardenas MK, Mirelman AJ, et al. The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru. BMC Health Services Research 2015;15:483. Download from BioMed
  • Castelli A, Daidone S, Jacobs R, Kasteridis P, Street A. The determinants of costs and length of stay for hip fracture patients. PLoS One 2015;10(7):e0133545. Download from Plosone
  • Castelli A, Street A, Verzulli R, Ward P. Examining variations in hospital productivity in the English NHS. European Journal of Health Economics 2015;16(3):243-254. Download from Springer
  • Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: An economic evaluation of data from a randomised controlled trial. The Lancet Infectious Diseases 2015;15(12):1459-1466. Download from The Lancet
  • Clark AL, Johnson M, Fairhurst C, Torgerson D, Cockayne S, Rodgers S, Griffin S, et al. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure. Health Technology Assessment 2015;19(75). Download from NIHR
  • Claxton K, Griffin S, Koffijberg H, McKenna C. How to estimate the health benefits of additional research and changing clinical practice. BMJ 2015;351:h5987. Download from bmj
  • Claxton KP, Martin S, Soares MO, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Methods for the estimation of the NICE cost effectiveness threshold. Health Technology Assessment 2015;19(14). Download fron NIHR
  • Claxton K, Sculpher M, Palmer S, Culyer AJ. Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients? Health Economics 2015;24(1):1–7. Download from Wiley
  • Conigliani C, Manca A, Tancredi A. Prediction of patient reported outcome measures via multivariate ordered probit models. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2015;178(3):567-591. Download from Wiley
  • Cookson R. Justice and the NICE approach. Journal of Medical Ethics 2015;41(1):99-102. Download from BMJ
  • Cookson R, Gutacker N, Garcia-Armesto S, et al. Socioeconomic inequality in hip replacement in four European countries from 2002 to 2009 – area level analysis of hospital data. European Journal of Public Health 2015;25(suppl1):21-27. Download from Oxford journals
  • Corbett M, Heirs M, Rose M, Smith A, Stirk L, Richardson G, et al. The delivery of chemotherapy at home: an evidence synthesis. Health Services and Delivery Research 2015;3:14. Download from NIHR
  • Dakin H, Devlin N, Feng Y, Rice N, et al. The influence of cost-effectiveness and other factors on NICE decisions. Health Economics 2015;24(10):1256-1271. Download from Wiley
  • de Goeij MCM, Suhrcke M, Toffolutti V, et al. How economic crises affect alcohol consumption and alcohol-related health problems: a realist systematic review. Social Science & Medicine 2015;131:131-146. Download from Sciencedirect
  • Di Novi C, Jacobs R, Migheli M. The quality of life of female informal caregivers: from Scandinavia to the Mediterranean sea. European Journal of Population 2015;31(3):309-333. Download from springer
  • Drummond M. When do performance-based risk-sharing arrangements make sense? The European Journal of Health Economics 2015;16(6):569-571. Download from Springer
  • Drummond M, Husereau D. David Sackett 1934 – 2015. Value in Health 2015;18(5):549. Download from Value in Health
  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods For The Economic Evaluation of Health Care Programmes. Fourth Edition: Oxford: Oxford University Press;2015. Download from OUP
  • Duarte A, Walker J, Walker S, Richardson G, Holm Hansen C, Martin P, Murray G, Sculpher M, Sharpe M. Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer. Journal of Psychosomatic Research 2015;79(6):465-70. Download from ScienceDirect
  • Dusheiko M, Gravelle H, Martin S, Smith PC. Quality of disease management and risk of mortality in English primary care practices. Health Services Research 2015;50(5):1452-1471. Download from Wiley
  • Faria R, Hernandez Alava M, Manca A, Wailoo A. The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data. NICE DSU technical support document 17;2015. NICE.
  • Faria R, Weatherly HLA, Kiss N, Manca A, Parker GM, Beresford B A, Aspinal FJ. The challenges in evaluating the cost-effectiveness of complex interventions. Value in Health 2015;18(7):A727-A728. Download from Value in Health
  • Galdas P, Darwin Z, Fell J, Kidd L, Bower P, Blickem C, McPherson K, Hunt K, Gilbody S, Richardson G. A systematic review and metaethnography to identify how effective, cost-effective, accessible and acceptable self-management support interventions are for men with long-term conditions (SELF-MAN). Health Services and Delivery Research 2015;3(34). Download from NIHR
  • Galdas P, Fell J, Bower P, et al, Richardson G. The effectiveness of self-management support interventions for men with long term conditions: a systematic review and meta-analysis. BMJ Open 2015;5(3):e006620. Download from BMJ   
  • Gaughan J, Gravelle H, Siciliani L. Testing the bed-blocking hypothesis: does nursing and care home supply reduce delayed hospital discharges? Health Economics 2015;24(S1):32–44. Download from Wiley
  • Giannopoulou C, Sideris E, Wade R, Moe-Byrne T, Eastwood A, McKenna C.  Ipilimumab for previously untreated unresectable malignant melanoma: a critique of the evidence. PharmacoEconomics 2015;33(12):1269-1279. Download from Springer
  • Goddard M. Competition in healthcare: Good, bad or ugly? International Journal of Health Policy and Management 2015;4(9):567-569. Download from IJHPM
  • Goddard M, Sheldon T. Reflecting on the impact of health services research on society. Journal of Health Services Research & Policy 2015;20(4):201. Download from Sage journals
  • Goryakin Y, Lobstein T, James WPT, Suhrcke M. The impact of economic, political and social globalization on overweight and obesity in 56 low and middle income countries. Social Science & Medicine 2015;133:67-76. Download from Sciencedirect
  • Goryakin Y, Rocco L, Suhrcke M, Roberts B, McKee M. Fruit and vegetable consumption in the former Soviet Union: the role of individual and community-level factors. Public Health Nutrition 2015;18(15):2825-1835. Download from Cambridge journals
  • Goryakin Y, Suhrcke M, Roberts B, McKee M. Mental health inequalities in 9 former Soviet Union Countries: evidence from the previous decade. Social Science & Medicine 2015;124:142-51. Download from ScienceDirect
  • Grašič K, Mason AR, Street A. Paying for the quantity and quality of hospital care: the foundations and evolution of payment policy in England. Health Economics Review 2015;5(15). Download from Health economics review
  • Gutacker N, Bloor K, Cookson R. Comparing the performance of the Charlson/Deyo and Elixhauser co-morbidity indices across five European countries and three conditions. European Journal of Public Health 2015;(suppl1):15-20. Download from Oxford journals
  • Gutacker N, Bloor K, Cookson R, Garcia-Armesto S, Bernal-Delgado E. Comparing hospital performance within and across countries: an illustrative study of coronary artery bypass graft surgery in England and Spain. European Journal of Public Health 2015;25(suppl1):28-34. Download from Oxford journals
  • Gutacker N, Harris A, Brennan D, Hollingsworth B. The determinants of dentists’ productivity and the measurement of output. Social Science & Medicine 2015;124:76-84. Download from ScienceDirect
  • Gutacker N, Mason A, Kendrick T, Goddard M, Gravelle H, Gilbody S, Aylott L, Wainwright J, Jacobs R. Does the quality and outcomes framework reduce psychiatric admissions in people with serious mental illness? A regression analysis. BMJ Open 2015;5(4):e007342. Download from bmjopen
  • Gutacker N, Street A, Gomes C, Bojke C. Should English healthcare providers be penalised for failing to collect patient-reported outcome measures (PROMs)? A retrospective analysis. Journal of the Royal Society of Medicine 2015;108(8):304-316. Download from sagepub
  • Halliday S, Formby A, Cookson R. An assessment of the court’s role in the withdrawal of clinically assisted nutrition and hydration from patients in the permanent vegetative state. Medical Law Review 2015;23(4):556-587. Download from Oxford Academic
  • Harris M, Knott R, Lorgelly P, Rice N. Survey self-assessments, reporting behaviour and the use of externally collected vignettes. Bankwest Curtin Economics Centre Working Paper 15/8;Perth:Curtin University. 2015. Download from Curtin
  • Hernandez-Quevedo C, Weatherly H. Health promotion, disease prevention and health inequalities. In McDaid D, Sassi F, Merkur S (eds.). Promoting Health, Preventing Disease: The Economic Case. Chapter 12;pp:259-278. 2015. Open University Press, Maidenhead, UK.  
  • Hinde S, McKenna C, Whyte S, Peake M, Callister M, Rogers T, Sculpher M. Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small cell lung cancer. British Journal of Cancer2015;113(1):135-41. Download from BJC
  • Hinde S, Spackman E. Bidirectional citation searching to completion: an exploration of literature searching methods. Pharmacoeconomics 2015;33(1):5-11. Download from Springer
  • Howdon D, Jones AM. A discrete latent factor model for smoking, cancer and mortality. Economics & Human Biology 2015;18:57-73. Download from Elsevier
  • Husereau D, Drummond M, Petrou S, et al. Reply to Roberts et al.: CHEERS is sufficient for reporting cost-benefit analysis, but may require further elaboration. PharmacoEconomics 2015;33(5):535-536. Download from Springer
  • Ijzerman M, Manca A, Keizer J, Ramsey S. Implementation of comparative effectiveness research in personalized medicine applications in oncology: current and future perspectives. Comparative Effectiveness Research 2015;5:65-72. Download from Dovepress
  • Jacobs R, Gutacker N, Mason A, Goddard M, Gravelle H, Kendrick T. Do higher primary care practice performance scores predict lower rates of emergency admissions for persons with serious mental illness? An analysis of secondary panel data. NIHR HS & DR Journal 2015;3(16). Download from NIHR
  • Jacobs R, Gutacker N, Mason A, Goddard M, Gravelle H, et al. Determinants of hospital length of stay for people with serious mental illness in England and implications for payment systems: a regression analysis. BMC Health Services Research 2015;15:439. Download from Biomed Central
  • Johnson M, Kanaan M, Richardson G, et al.  A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease. BMC Medicine 2015;13:213. Download from BioMed Central
  • Jones AM, Lomas J, Moore PT, Rice N. A quasi-Monte-Carlo comparison of parametric and semiparametric regression methods for heavy-tailed and non-normal data: an application to healthcare costs. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2015;doi:10.1111/rssa.12141. Download from Wiley
  • Jones AM, Lomas J, Rice N. Healthcare cost regressions: going beyond the mean to estimate the full distribution. Health Economics 2015;24(9):1192-1212. Download from Wiley
  • Kasteridis P, Mason A, Goddard M, Jacobs R, Santos R, McGonigal G. The influence of primary care quality on hospital admissions for people with dementia in England: a regression analysis. PLoS One 2015;10(3):e0121506. Download from plosone, Dementia Lay Summary (PDF , 353kb),
  • Kasteridis P, Street A, Dolman M, et al. Who would benefit most for improved integrated care? Implementing an analytical strategy in South Somerset. International Journal of Integrated Care 2015;15:Jan-Mar:1-11. Download from ijic
  • Khan J, Trujillo A, Ahmed S, Siddiquee AT, Alam N, Mirelman A, et al. Distribution of chronic disease mortality and deterioration in household socioeconomic status in rural Bangladesh: an analysis over a 24-year period. International Journal of Epidemiology 2015;44(6):1917-1926. Download from Oxford Academic
  • Kronenberg C, Jacobs R, Zucchelli E. The impact of a wage increase on mental health: Evidence from the UK minimum wage. Health, Econometrics and Data Group (HEDG), University of York 2015; working paper 15/08. Download from HERC
  • Kumar G, Woods B, et al. Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S. Lung Cancer 2015;89(3):294-300. Download from ScienceDirect
  • Lakshman R, Whittle F, Hardeman W, Suhrcke M, et al. Effectiveness of a behavioural intervention to prevent excessive weight gain during infancy (The Baby Milk Trial): study protocol for a randomised controlled trial. Trials 2015;16:442. Download from Trialsjournal
  • Lipton JH, Bryden P, Sidhu MK, et al, Woods B, et al. Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors. Leukemia Research 2015;39(1):58-64. Download from Elsevier
  • Littlewood E, Duarte A, Hewitt C, Knowles S, Palmer S, Walker S, et al on behalf of the REEACT Team. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. Health Technology Assessment 2015;19(101). Download from NIHR
  • Love-Koh J, Asaria M, Cookson R, Griffin S. The social distribution of health: Estimating quality-adjusted life expectancy in England. Value in Health 2015;18(5):655-662. Download from ScienceDirect
  • Mannion R, Davies H, Freeman T, Millar R, Jacobs R, Kasteridis P. Overseeing oversight: governance of quality and safety by hospital boards in the English NHS. Journal of Health Services Research and Policy 2015;20:(1):1-8. Download from Sagepub
  • Martin A, Panter J, Suhrcke M, Ogilvie D. Impact of changes in mode of travel to work on changes in body mass index: evidence from the British Household Panel Survey. Journal of Epidemiology & Community Health 2015;69(8):753-761. Download from BMJ
  • Mason A, Goddard M, Weatherly H, Chalkley M. Integrating funds for health and social care: an evidence review. Journal of Health Services Research & Policy 2015;20(3):177-188. Download from Sagepub
  • McGuire A, Drummond MF, Martin M, Just N. End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes? Expert Review of Pharmacoeconomics and Outcomes Research 2015;15(4): 599-605. Download from Tandfonline
  • McKenna C, Soares M, Claxton K, Bojke L, Griffin S, Palmer S, Spackman E. Unifying research and reimbursement decisions: case studies demonstrating the sequence of assessment and judgments required. Value in Health 2015;18(6):865-875. Download from ScienceDirect
  • McMillan A, Bratton D, Faria R, et al. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. Health Technology Assessment 2015;19(40). Download from NIHR
  • Mirelman A, Blythe Ballard S, Saito M, et al. Cost-effectiveness of norovirus vaccination in children in Peru. Vaccine 2015;33(27):3084-3091. Download from ScienceDirect
  • Monsivais P, Martin A, Suhrcke M, et al. Job-loss and weight gain in British adults: Evidence from two longitudinal studies. Social Science & Medicine 2015;143:223-231. Download from Sciencedirect
  • Montresor A, A Porta N, Albonico M, Gabrielli AF, Jankovic D, et al. Soil-transmitted helminthiasis: the relationship between prevalence and classes of intensity of infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 2015;109(4):262-267. Download from Oxford Academic
  • Moran V, Jacobs R. Comparing the performance of English mental health providers in achieving patient outcomes. Social Science & Medicine 2015;140:127-136. Download from Elsevier
  • Nakamura R, Suhrcke M, et al. Price promotions on healthier vs. less healthy foods: a hierarchical regression analysis of the impact on sales and social patterning of responses to promotions in Great Britain. American Journal of Clinical Nutrition 2015;101(4):808-816. Download from AJCN
  • Pan J, Liu D, Ali S. Patient dissatisfaction in China: What matters. Social Science and Medicine 2015;143:145-153. Download from ScienceDirect
  • Pennington M, Baker R, Werner B, et al, Manca A, The EuroVaQ Team. Comparing WTP values of different types of QALY gain elicited from the general public. Health Economics 2015;24(3):280-293. Download from Wiley
  • Phillips A, et al, Revill P. (Working group on modelling of antiretroviral therapy monitoring strategies in sub-Saharan Africa). Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature2015;528:7580:S68–S76. Download from nature
  • Pichon-Riviere A, Garay OU, Augustovski F, Vallejos C, Huayanay L, del Pilar Navia Bueno M, Rodriguez A, Coelho de Andrade CJ, Buendia JA, Drummond MF. Implications of global pricing policies on access to innovative drugs: the case of trastuzumab in seven Latin American countries. International Journal of Technology Assessment in Health Care 2015;31(1-2):2-11. Download from Cambridge UP
  • Portrait F, Bakker M, Slootman B, Gafni A, van den Berg B. How do patients receiving radiotherapy in a Dutch hospital value their time? A contingent valuation study. Journal of Radiotherapy in Practice 2015;14(2):152-161. Download from Cambridge UP
  • Revill P, Hallett T, Phillips A. The costs and benefits of alternatives approaches to monitoring patients on antiretroviral therapy: modelling and economic analysis, HIV Modelling Consortium report for the World Health Organization HIV Treatment Guidelines Development Committee 2015. Download from HIV modelling 
  • Revill P, Walker S, Mabugu T, Nathoo KJ, Mugyenyi P, Kekitinwa A, et al, Sculpher M, Gibb DM. Opportunities for improving the efficiency of paediatric HIV treatment programmes. AIDS 2015;29(2):201-210. Download from Wolters Kluwer
  • Revill P, Woods B, Sculpher M. Economic evaluation of healthcare programs and interventions: Applications to low- and middle-Income. In: Scheffler RM, (ed). World Scientific Handbook of Global Health Economics and Public Policy Volume 1 2015. More details
  • Ricciardi GW, Toumi M, Weil-Olivier C, et al, Drummond M. Comparison of NITAG policies and working processes in selected developed countries. Vaccine 2015;33(1):3-11. Download from Elsevier
  • Richardson R, Trépel D, Perry A, Ali S, Duffy S, Gabe R, Gilbody S, Glanville J, Hewitt C, Manea L, Palmer S, et al. Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model. Health Technology Assessment 2015;19(1). Download from NIHR
  • Ripley DP, Brown JM, Everett CC,  Bijsterveld P, Walker S, Sculpher M, et al. Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC ): A prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease. American Heart Journal 2015;169(1):17-24e1. Download from ahjonline
  • Robling M, Bekkers M-J, Bell K, Butler C, et al, Richardson G, et al. Effectiveness of a nurse-led intensive home-visitation programme for first-time teenage mothers (Building Blocks): a pragmatic randomised controlled trial. The Lancet 2015;387(10014):146-155. Download  from The Lancet
  • Rogowski W, Payne K, Schnell-Inderst P, Manca A, et al. Concepts of ‘personalization’ in personalized medicine: implications for economic evaluation. PharmacoEconomics 2015;33(1):49-59. Download from Springer
  • Ruggeri M, Manca A, Coretti S, et al. Investigating the generalizability of economic evaluations conducted in Italy: A critical review. Value in Health;2015:18(5):709-20. Download from Value in Health
  • Santana P, Santos R, Alves I, et al. Avaliação das condições individuais e contextuais no peso dos recém‐nascidos (filhos de mães imigrantes e portuguesas) na área metropolitana de Lisboa. Revista Portuguesa de Saude Publica 2015;33(2):157-169. Download from Sciencedirect 
  • Scott DA, Woods B, Thompson JC, et al.  Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Pulmonary Medicine 2015;15:145. Download from biomedcentral
  • Sculpher M, Clinical trials provide essential evidence, but rarely offer a vehicle for cost-effectiveness analysis. Value in Health 2015;18(2):141-2. Download from Value in Health
  • Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics 2015;33(8):811-831. Download from Springer
  • Seuring T, Goryakin Y, Suhrcke M. The impact of diabetes on employment in Mexico. Economics & Human Biology 2015;18:85-100. Download from Sciencedirect
  • Shepherd K, Hubbard D, Fenton N, Claxton K, et al. Policy: Development goals should enable decision-making. Nature 2015;523(7559):152-154. Download from Nature 
  • Stamuli E, Richardson G, Duffy S, et al. Systematic review of the economic evidence on home visitation programmes for vulnerable pregnant women. British Medical Bulletin 2015;115(1):19-44. Download from Oxford UP 
  • Sorenson C, Drummond MF, et al. The role of hospital payments in the adoption of new medical technologies: an international survey of current practice. Health Economics, Policy and Law 2015;10(2):133-59. Download from Cambridge UP
  • Street A. Not as it seems: Productivity growth isn't always a good thing. Health Service Journal 9 April 2015.
  • Suhrcke M, Kenkel D. Social determinants of health: early childhood development and education. In: McDaid D, Sassi S, Merkur S (eds.). Promoting Health, Preventing Disease: The Economic Case. Chapter 11;pp:237-256. 2015. Open University Press, Berkshire, UK. 
  • Threlfall AG, Meah S, Fischer AJ, Cookson R, et al. The appraisal of health interventions: The use of theory. Journal of Public Health 2015;37(1):166-171. Download from Oxford journals
  • Tsoi B, O’Reilly D, Masucci L, Drummond MF, et al. Harmonization of HTA-based reimbursement and regulatory approval activities: a qualitative study. Journal of Population Therapeutics and Clinical Pharmacology 2015;22(1):e78-e89. Download from JPTCP
  • Vogl M, Leidl R, Plotz W, Gutacker N. Comparison of pre- and post-operative health-related quality of life and length of stay after primary total hip replacement in matched English and German patient cohorts. Quality of Life Research 2015;24(2):513-520. Download from springer
  • Waddell KM, Kagame K, Ndamira A, Twinamasiko A, Picton SV, Simmons IG, Revill P, et al. Improving survival of retinoblastoma in Uganda. British Journal of Ophthalmology 2015;99(7):937-942. Download from bjo 
  • Wade R, Duarte A, Simmonds M, Rodriguez-Lopez R, Duffy S, Woolacott N, Spackman E. The clinical and cost effectiveness of aflibercept in combination with irinotecan and fluorouracil-based therapy (FOLFIRI) for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy: a critique of the evidence. Pharmacoeconomics 2015;33(5):457-466. Download from Springer
  • Wade R, Sideris E, Paton F, Rice S, Palmer S, Fox D, Woolacott N, Spackman E. Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis. Health Technology Assessment 2015;19(98). Download from NIHR
  • Welton N J, Soares MO, Palmer S et al. Accounting for heterogeneity in relative treatment effects for use in cost-effectiveness models and value-of-information analyses. Medical Decision Making 2015;35(5):608-621. Download from Sage
  • Westby MJ, Dumville JC, Soares MO, et al. Dressings and topical agents for treating pressure ulcers. Cochrane Database of Systematic Reviews 2015;Issue 11:Art No.:CD011947. Download from Wiley
  • Wilkinson G, Drummond MF. Alternative approaches for assessing the socioeconomic benefits of medical devices: a systematic review. Expert Review of Medical Devices 2015;12(5):629-648. Download from tandfonline
  • Woods B, Hawkins N, Mealing S, Sutton A, Abraham WT, Beshai JF, Klein H, Sculpher M et al. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 2015;101(22):1800-1806. Download from Heart
  • Woods B, Llewellyn A, Faria R, Simmonds M, Lomas J, Harden M, Woolacott N, Griffin S. Evidence Review Group's Report: Daclatasvir for treating chronic hepatitis C. TA364 Report to NICE. 2015. Download from NICE
  • Wright B, Barry M, Hughes E, Trépel D, Ali S, Allgar V, Cottrill L, Duffy S, Fell J, Glanville J, Glaser D, Hackney L, Manea L, McMillan D, Palmer S et al. Clinical effectiveness and cost-effectiveness of parenting interventions for children with severe attachment problems: a systematic review and meta-analysis. Health Technology Assessment 2015;19(52). Download from NIHR

2014

2014

  • Allen T, Sutton M, Cookson R. How do economic incentive schemes influence rationing decisions by primary care physicians?  In: Danis M, Hurst SA, Fleck L, Forde R, Slowther A. (Eds).  Fair Resource Allocation and Rationing at the Bedside.Oxford University Press;2014:Ch7.
  • Ara R, Basarir H, Keetharuth A, Barbieri M, Weatherly H, Sculpher M et al. Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. International Journal of Technology Assessment in Health Care 2014;30(4):381-393. Download from Cambridge Journals
  • Asaria M, Cookson R, Griffin S. ‌In:Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp.22-26.
  • Ashby RL, Gabe R, Ali S, Adderley UJ, Bland M, et al (includes Soares M). Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers  (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial. Lancet 2014;383(9920):871-879.
  • Ashby RL, Gabe R, Ali S, Saramago P et al (includes Soares M). VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. Health Technology Assessment 2014;18(57). Download from NIHR
  • Barbieri M, Richardson G, Paisley S, Sculpher M. Rapid review of existing literature on the cost-effectiveness of alternative systems for diagnosis and referral of any cancer in primary care. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014; Research Report 020. Download from EEPRU
  • Barbieri M, Richardson G, Paisley S, Sculpher M. Rapid review of existing literature on the cost-effectiveness of follow-up strategies after cancer treatment. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) Research Report 021. Download from EEPRU
  • Barbieri M, Weatherly H, Ara R, Basarir H, Sculpher M et al. What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. Applied Health Economics and Health Policy 2014;12(5):497-510. Download from Springer
  • Bardsley M, Street A. Cost of integrated care. In: Curtis L. (ed). Unit Costs of Health & Social Care 2014. PSSRU University of Kent, Canterbury;2014:pp13-18. Download from PSSRU
  • Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin S (includes Sculpher M). Effect of management strategies and clinical status on costs of care for advanced HIV. American Journal of Managed Care 2014;20(5):129-137. Download from AJMC
  • Bartoll X, Palencia P, Malmusi D, Suhrcke M, Borrell C. The evolution of mental health during the Spanish economic crisis. European Journal of Public Health 2014;24(3):415-418. 
  • Blakeman T, Blickem C, Kennedy A, Reeves D, Bower P et al (includes Richardson G, Spackman E). Effect of information and telephone-guided access to community support for people with chronic kidney disease: randomised controlled trial. PLoS ONE 2014;9(10):e109135.
  • Bojke L, Soares M. Decision analysis: Eliciting experts’ beliefs to characterise uncertainties. In:Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014:pp149-154. 
  • Brekke KR, Gravelle H, Siciliani L, Straume OR. Patient choice, mobility and competition among health care providers. In: Levaggi R, Montefioro M (eds). Health Care Provision and Patient Mobility. Vol.12. Springer;2014 pp. 1-26.
  • Briggs A, Drummond MF. Reporting guidelines for health economic evaluation: BMJ guidelines for authors and peer reviewers of economic submissions. In:Moher D, Altman DG, Schulz KF, Simera I, Wager E (eds.) Guidelines for Reporting Health Research: A Users Manual. John Wiley & Sons;2014. 
  • Brilleman SL, Gravelle H, Hollinghurst S et al.  Keep it simple? Predicting primary health care costs with clinical morbidity measures. Journal of Health Economics 2014; 35:109-122.
  • Buxton M, Longworth L, Raftery J, Sculpher M, Towse A.  Reforming the cancer drug fund: focus on drugs that might be shown to be cost effective. BMJ 2014;349:g7276. Download from BMJ
  • Callery P, Kyle RG, Weatherly H, Banks M et al. Substituting community children's nursing services for inpatient care: a case study of costs and effects. Emergency Medicine Journal 2014;31(e55-e59). Download from BMJ.
  • Carrieri V, Di Novi C, Jacobs R, Robone S. Insecure, sick and unhappy? Well-being consequences of temporary employment contracts, Chapter 4. In: Polachek SW, Tatsiramos K (eds). Factors Affecting Worker Well-Being: The Impact of Change in the Labor MarketBook Series. Research in Labor Economics Vol.40. 2014;pp. 157-193:Emerald Group Publishing Limited:ISBN:978-1-78441-150-3.
  • Cary M, Byford S, Faria R. Measurement and valuation of health outcomes for economic evaluation and decision-making in healthcare. In Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 5-14. 
  • Chan AK, Ford D, Namata H, Muzambi M et al (includes Revill P). The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Services Research 2014;14:352.
  • Christiansen T, Cookson R, Gutacker N et al. Handbook on methodology: Measurement of socioeconomic equity; ECHO 2014: Apr 27.
  • Claxton K, Revill P, Sculpher M, Wilkinson T, Cairns J, Briggs A. The Gates Reference Case for Economic Evaluation. The Bill and Melinda Gates Foundation;2014. Methods for Economic Evaluation Project (MEEP) (PDF , 2,265kb)
  • Cockayne S, Pattenden J, Worthy G, Richardson G, Lewin R. Nurse facilitated Self-management support for people with heart failure and their family carers (SEMAPHFOR): a randomised controlled trial. International Journal of Nursing Studies 2014;51(9); 1207-1213. 
  • Conklin AI, Forouhi NG, Suhrcke M, Surtees P et al. Variety more than quantity of fruit and vegetable intake varies by socioeconomic status and financial hardship. Findings from older adults in the EPIC cohort. Appetite 2014;83: 248-55.
  • Cookson R, Griffin S, Nord E. Incorporation of concerns for fairness in economic evaluation of health programs: overview. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp27-34.
  • Cookson R, Suhrcke M. Public Health: Overview. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego :Elsevier;2014. pp. 210-217. 
  • Drummond M. Why has Sweden been so prominent in health economics? In: Culyer A, Kobelt G, (eds). Portrait of a Health Economist. Lund, Sweden. The Swedish Institute for Health Economics 2014;pp:39-44.
  • Drummond M, de Pouvourville G, Jones E et al. A comparative analysis of two contrasting European approaches for rewarding the value added by drugs for cancer: England versus France. Pharmacoeconomics 2014;32(5):509-20.
  • Drummond M, Towse A. Orphan drugs policies: a suitable case for treatment. European Journal of Health Economics 2014;15(4):335-340.
  • Duarte A. Discounting in economic valuation of healthcare interventions. In Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 15-24.
  • Dusheiko M. Patient choice and mobility in the UK health system: internal and external markets. In : Levaggi R, Montefioro M (eds). Health Care Provision and Patient Mobility,Vol.12. Springer;2014 pp.81-132. 
  • Eaton J, Menzies NA, Stover J, et al (includes Revill P). Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health 2014;2(1):e23-34. Download from the Lancet
  • Epstein D, Sculpher MJ, Powell JT et al. Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trials.  British Journal of Surgery 2014;101(6):623–631.
  • Espinoza MA, Manca A, Claxton K, Sculpher MJ. The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Medical Decision Making 2014;34(8):951-964. Download from sagepub
  • Espinoza MA, Sculpher MJ, Manca A, Basu A. Analysing heterogeneity to support decision making. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp.71-76.
  • Faria R, Barbieri M, Light K, Elliott KA, Sculpher MJ. The economics of medicines optimization: policy developments, remaining challenges and research priorities. British Medical Bulletin 2014;111(1):45-61. Download from Oxfordjournals
  • Faria R, Barbieri M, Light K, Sculpher M. Economics of Medicines Optimisation: Report for the Department of Health. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014;research report 016:pp38. Download from EEPRU
  • Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32(12):1157-1170. Download from springer
  • Faria R, McKenna C, Palmer S. Optimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis. Value in Health 2014;17(8): 772-782. 
  • Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.;IETS:2014.pp55.
  • Faria R, Revill P. Decision rules in economic evaluation of healthcare interventions. In Faria R, Mejia A (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 42-54. 
  • Faria R, Walker S, Whyte S, Dixon S, Palmer S, Sculpher M. Getting cost-effective technologies into practice: the value of implementation. An application to novel anticoagulants in the prevention of stroke and systemic embolism. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014; Research Report 022:pp82. Download from EEPRU
  • Gaughan J. Kobel C. Coronary artery bypass grafts and diagnosis related groups: Patient classification and hospital reimbursement in 10 European countries. Health Economics Review 2014;4(4).
  • Gavan S, Harrison M, Iglesias Urrutia CP, Barton A, Manca A, Payne K. Economics of stratified medicine in rheumatoid arthritis. Current Rheumatology Reports 2014;16:468.
  • Goryakin Y, Suhrcke M. The prevalence and determinants of catastrophic health expenditures attributable to non-communicable diseases in low- and middle-income countries: a methodological commentary. International Journal for Equity in Health 2014;13:107. 
  • Goryakin Y, Suhrcke M. Economic development, urbanisation, technological change and overweight: what do we learn from 244 Demographic and Health Surveys? Economics and Human Biology 2014;14:109–127. 
  • Gravelle H, Santos R, Siciliani L. Does a hospital’s quality depend on the quality of other hospitals? A spatial econometrics approach. Regional Science and Urban Economics 2014;49:203-216. Download from ScienceDirect
  • Griffiths A, Paracha N, Davies A, Branscombe N, Cowie MR, Sculpher MJ. The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective. Heart 2014;100:1031-1036. Download from BMJ
  • Haakma W, Steuten LM, Bojke L, IJzerman MJ. Belief elicitation to populate health economic models of medical diagnostic devices in development. Applied Health Economics and Health Policy 2014;12(3):327-34.
  • Hall J, Buckley HL, Lamb KA, Stubbs N, Saramago Pet al. Point prevalence of complex wounds in a defined United Kingdom population. Wound Repair and Regeneration 2014;22(6):694-700.
  • Hallett TB, Menzies NA, Revill P, Keebler D et al. Using modeling to inform international guidelines for antiretroviral therapy. AIDS 2014;28(S1):S1-S4.
  • Harrison M, Dusheiko M, Sutton M, Gravelle H, Doran T, Roland M. Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study. BMJ 2014;349:g6423. 
  • Hinde S, Soares M, Burch J, Marson A, Woolacott N, Palmer S. The added clinical and economic value of diagnostic testing for epilepsy surgery. Epilepsy Research 2014;108(4)775-781. Download from sciencedirect
  • Jacobs R. Payment by results for mental health services: economic considerations of case-mix funding. Advances in Psychiatric Treatment 2014;20:155-164.
  • Jones AM, Laporte A, Rice N, Zucchelli E. A synthesis of the Grossman and Becker-Murphy models of health and addiction: theoretical and empirical implications. Health, Econometrics and Data Group (HEDG), University of York 2014; working paper 14/07. Download from HERC
  • Jones AM, Lomas J, Rice N. Going beyond the mean in healthcare cost regressions: a comparison of methods for estimating the full conditional distribution. Health Econometrics and Data Group (HEDG), University of York 2014;working paper 14/26. Download from HERC
  • Jönsson L, Sandin R, Ekman M, Ramsberg J, Charbonneau C, Huang X, Jönsson B, Weinstein M, Drummond MF. Analyzing overall survival in randomized controlled trials with cross-over and implications for economic evaluation. Value in Health 2014;17(6);707-713.
  • Kasteridis P, Yen S. Occasional smoking and body weight among adults. Applied Economic Perspectives and Policy 2014;36(3):479-503.
  • Keebler D, Revill P et al (includes Walker S). Cost effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Lancet Global Health 2014;2(1):e35-43.
  • Kronenberg C, Barros P. Catastrophic healthcare expenditure–drivers and protection: The Portuguese case. Health Policy 2014;115(1):44-51. Download from elsevier
  • Lin B, Ver Ploeg M, Kasteridis P, Yen ST. The roles of food prices and food access in determining food purchases of low-income households. Journal of Policy Modeling 2014;36(5):938-952.
  • Listl S, Chalkley M. Provider payment bares teeth: Dentist reimbursement and the use of check-up examinations. Social Science & Medicine 2014;111:110-116.
  • Madan J, Ades AE, Price M, Maitland K, Jemutai J, Revill P, Welton NJ. Strategies for the efficient computation of the expected value of partial perfect information. Medical Decision Making 2014;34(3):327-342. Download from sagepub 
  • Mason A, Goddard M, Weatherly H. Financial mechanisms for integrating funds for health and social care: do they enable integrated care?  International Journal of Integrated Care 2014;14(6);Annual Conference Supplement;URN:NBN:NL:UI:10-1-116181. 
  • McKenna C. Uncertainty and the value of additional evidence in health care decisions. In Faria R, Mejia A. (eds). Guidelines for the economic evaluation of healthcare technologies in Colombia: technical support documents. Instituto de Evaluación Tecnológica en Salud. Bogotá D.C.:IETS;2014 pp. 25-41.
  • McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. The Lancet, Respiratory Medicine 2014;2(10):804-812. 
  • Mejia A, Richardson G, Pattenden J, Cockayne S, Lewin R. Cost-effectiveness of a nurse facilitated, cognitive behavioural self-management programme compared with usual care using CBT manual alone for patients with heart failure: secondary analysis of data from the SEMAPHFOR trial. International Journal of Nursing Studies 2014;51(9):1214-1220.
  • Norheim O, Johri M, Chisholm D, et al (includes Cookson R). Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Effectiveness and Resource Allocation 2014;12:18.
  • Panagioti M, Richardson G, Small N, et al. Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis.  BMC Health Services Research 2014;14:356.
  • Penazzato M, Revill P, Prendergast AJ, Collins IJ, Walker S, Elyanu P, Sculpher M, Gibb D. Early infant diagnosis of HIV infection in low and middle income countries: Does one size fit all? Lancet Infectious Diseases 2014;14(7):650-655. Download from the lancet
  • Phillips A, Cambiano V, Miners A, Revill P, et al. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis. The Lancet HIV 2014;1(2):e85-e93. Download from Elsevier
  • Phillips A, Cambiano V, Nakagawa F et al (includes Revill P). Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings. PLoS ONE 2014;9(10);e109148. Download from plosone
  • Phillips AN, Munderi P, Revill P, El-Sadr WM, Lundgren JD. Antiretroviral therapy recommendations for the global community: aspiration versus reality. AIDS 2014;28(7):939-941. Download from aidsonline
  • Reeves D, Blickem C, Vassilev I, Brooks H, Kennedy A, Richardson G, Rogers A. The contribution of social networks to the health and self-management of patients with long-term conditions: A longitudinal study. PLoS ONE 2014;9(6):e98340.
  • Reeves D, Hann M, Rick J, Rowe K, et al, Richardson G, Kennedy A, Bower P. Care plans and care planning in the management of long-term conditions in the UK: A controlled prospective cohort study.  British Journal of General Practice 2014;64(626):e568-e575.
  • Saramago P, Chuang LH, Soares MO. Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data. BMC Medical Research Methodology 2014;14:105. Download from biomedcentral
  • Saramago P, Cooper NJ, Sutton AJ, Hayes M, Dunn K, Manca A, Kendrick D. Cost-effectiveness of interventions for increasing the possession of functioning smoke alarms in households with pre-school children: a modelling study. BMC Public Health 2014;14:459.
  • Sculpher M, Walker S, Hinde S, Claxton K. Research to inform resource allocation in health and social care. Results of a scoping study. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)2014; Research Report 017. Download from EEPRU
  • Shih Y-CT, Mullins CD, Drummond MF. The role of economic evaluation in meeting IOM's recommendations on delivering high-quality cancer care. Value in health 2014;17(5):497-500. 
  • Siciliani L, Moran V, Borowitz M. Measuring and comparing health care waiting times in OECD countries. Health Policy 2014;118(3):292-303. Download from healthpolicyjrnl 
  • Soares MO, Dumville J, Ades AE, Welton NJ. Treatment comparisons for decision making: facing the problems of sparse and few data. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2014;177(1):259-279. Download from wiley
  • Soares MO, Welton NJ, Harrison DA et al (includes Palmer SJ). Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost effectiveness and value of a further randomised controlled trial. Critical Care 2014;18(6):649.
  • Soárez PC, Soares MO, Novaes HM. Modelos de decisão para avaliações econômicas de tecnologias em saúde (Decision modeling for economic evaluation of health technologies). Ciência & Saúde Coletiva 2014;19(10):4209-4222. Download from scielo 
  • Sorenson C, Drummond M. Improving medical device regulation: the United States and Europe in perspective. The Milbank Quarterly 2014;92(1):114-50.
  • Spackman E, Richmond S, Sculpher M et al. Cost-effectiveness analysis of acupuncture, counselling and usual care in treating patients with depression: The results of the ACUDep trial. PLoS ONE 2014;9(11):e113726.
  • Spackman E, Sculpher M, Howard J et al. Cost effectiveness analysis of pre-operative transfusion in patients with Sickle Cell Disease using evidence from the TAPS trial. European Journal of Haematology 2014;92(3):249-55.
  • Street A. Don’t believe the hype, productivity is rising. Health Service Journal 17 January 2014.
  • Street A. Living through the NHS’s famine years. BMJ 2014;349:g6536. Download from BMJ
  • Street A, Castelli A. Eliminating poor productivity is key to NHS improvement. Health Service Journal 13 March 2014.
  • Street A, Gutacker N, Bojke C, Devlin N, Daidone S. Variations in outcome and costs among NHS providers for common surgical procedures: econometric analyses of routinely collected data. National Institute for Health Research. Health Services and Delivery Research 2014:2(1). Download from NIHR 
  • Street A, Kasteridis P, Martin J. Data is at the heart of Somerset's integration masterpiece, Health Service Journal, 10 April, 2014 http://www.hsj.co.uk/5069580.article# 
  • Tarricone R, Ferrè F, Torbica A, Drummond MF. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? Expert Review of Pharmacoeconomics & Outcomes Research 2014;14(5):707-718.
  • van den Berg B, Fiebig D, Hall J. Well-being losses due to care-giving. Journal of Health Economics 2014;35:123-131.
  • Victoor A, Hansen J, van den Akker-van Marle M E, van den Berg B, van den Hout W B, de Jong J D. Choosing your health insurance package: A method for measuring the public's preferences for changes in the national health insurance plan. Health Policy 2014;117(2):257-165.
  • Walker S, Faria R, Whyte S, Dixon S, Palmer S, Sculpher M. Getting cost-effective technologies into practice: the value of implementation. Report on framework for valuing implementation initiatives. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)2014;Research Report 024:pp26. Download from EEPRU
  • Walker S, Walker J, Richardson G, Palmer S, Wu Q et al (includes Sculpher M) Sharpe M. Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer. Psychological Medicine 2014:44(7):1451-1460. Download from Cambridge journals
  • Weatherly H, Cookson R, Drummond M. Economic evaluation of public health interventions: methodological challenges. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego: Elsevier; 2014. pp217-223.
  • Weatherly H, Faria R, van den Berg B. Valuing informal care for economic evaluation. In: Culyer AJ (ed.) Encyclopedia of Health Economics, Vol 1. San Diego:Elsevier;2014. pp459-467.
  • White J, Gutacker N, Jacobs R, Mason A. Hospital admissions for severe mental illness in England: Changes in equity of utilisation at the small area level between 2006 and 2010, Social Science & Medicine 2014;120:243-251. Download from Elsevier
  • Whyte S, Dixon S, Faria R, Walker S, Palmer S, Sculpher M. Getting cost-effective technologies into practice: the value of implementation. An application to B-type natriuretic peptide (BNP) testing in diagnosing chronic heart failure. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) 2014; Research Report 025:pp30. Download from EEPRU
  • Wilkinson G, Drummond M. Impact of reimbursement policies on the adoption of medical devices in an outpatient setting. Health Policy and Technology 2014;3(4):281-286. 

2013

2013

  • Asaria M, Griffin S, Cookson R. Measuring health inequality in the context of cost-effectiveness analysis. In Rosa Dias P, O’Donnell O (eds.) Health and Inequality (Research on Economic Inequality, Volume 21), Emerald Group Publishing Limited.pp:491-507. 2013. Download from emeraldinsight
  • Ashworth M, Schofield P, Doran T, Cookson R, Sutton M, Seed P, et al. The Public Health Impact (PHI) score – a new measure of public health effectiveness for general practices in England. British Journal of General Practice. 2013;63(609):291-9.
  • Barber S, Jackson C, Akhtar S, Bingham D, Ainsworth H, Hewitt C, Richardson G, Summerbell C, Pickett K, Moore H, Routen A, O’ Malley C, Brierley S, Wright J. "Pre-schoolers in the Playground” an outdoor physical activity intervention for children aged 18 months to 4 years old: Study protocol for a randomised controlled trial. Trials 2013;14(326).
  • Bayoumi A, Barnett P, Joyce V, Griffin S, Sun H, Bansback N, Holodniy M, Sanders G, Brown S, Kyriakides T, Angus B, Cameron W, Anis A, Sculpher M, Owens D. Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multi-drug resistant HIV disease. Jaids-Journal of acquired immune deficiency syndromes 2013;64(4):382-391.
  • Bes RE, Van den Berg B. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition. The Patient - Patient-Centered Outcomes Research 2013;6(2):75-80.
  • Blickem C, Blakeman T, Kennedy A, Bower P, Reeves D, Gardner C, Lee V, Chew-Graham C, Richardson G, Brooks H, Dawson, S, Mossabir R, Jariwala, P, Swallow A, Kontopantelis E, Gaffney H, Small N, Spackman E, Rogers A. The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled trial. Trials 2013;14(1):28.
  • Bojke C, Castelli A, Laudicella M, Street A, Ward P. Regional variation in the productivity of the English National Health Service. Health Economics 2013;22(2):194-211.
  • Brilleman SL, Purdy S, Salisbury C, Windmeijer F, Gravelle H, Hollinghurst S. Implications of comorbidity for primary care costs in the UK: a retrospective observational study. British Journal of General Practice 2013;63(609):e274-e82.
  • Brown S, Dietrich M, Ortiz-Nuñez A, Taylor K. Business ownership and attitudes towards risk. Applied Economics 2013:45(13): 1731-40.
  • Busse R, Geissler A, Aaviksoo A, Cots F, Häkkinen U, Kobel C, Mateus C, Or Z, O’Reilly J, Serdén L, Street A, Swan Tan S, Quentin W. Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? British Medical Journal 2013;346(F3197). Download from BMJ
  • Callery P, Kyle R, Weatherly H, Banks M, Ewing C, Powell P, Kirk S. Comparison of the costs of care during acute illness by two community children's nursing teams. Emergency Medicine 2013;30:1029-1032. Download from bmj
  • Castelli A, Jacobs R, Goddard M, Smith PC. Health, policy and geography: insights from a multi-level modelling approach. Social Science & Medicine 2013;92:61-73.
  • Cookson, R. Can the NICE ‘‘end-of-life premium’’ be given a coherent ethical justification? Health Politics, Policy and Law 2013;38(6):1129-1148.
  • Cookson R. Can money teach morality? Commentary on Disney, Le Grand and Atkinson. From irresponsible knaves to responsible knights for Just 5p: behavioural public policy and the environment. In Oliver A (ed). Behavioural Public Policy. Cambridge University Press 2013:pp 88-93.
  • Cookson R, Laudicella M, Li Donni P. Does hospital competition harm equity? Evidence from the English National Health Service. Journal of Health Economics 2013;32(2):410-422.
  • Cookson R, Sainsbury R, Glendinning C. (eds.) Jonathan Bradshaw on Social Policy: Selected Writings 1972-2011, University of York, York, 2013.
  • Daidone S, Street AD. How much should be paid for specialised treatment? Social Science and Medicine 2013;84:110-8. Download from Sciencedirect
  • Dakin H, Devlin N, Feng Y, Rice N, O’Neill P, Parkin D. The influence of cost-effectiveness and other factors on NICE decisions. Office for Health Economics (OHE) Research Paper 13/06; London, November 2013.
  • Dakin H, Devlin N, Feng Y, Rice N, O’Neill P, Parkin D. The influence of cost-effectiveness and other factors on NICE decisions. Health Economics Research Centre Research (HERC) Paper 01/13; University of Oxford, November 2013.
  • Davies A, Bakhai A, Schmitt C, Barrett A, Graham-Clarke P, Sculpher M. Prasugrel vs clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a model-based cost-effectiveness analysis for Germany, Sweden, the Netherlands, and Turkey. Journal of Medical Economics 2013;16(4):510–521.
  • Drummond MF. Twenty years of using economic evaluations for drug reimbursement decisions. What has been achieved? Journal of health politics policy and law 2013;38(6):1081-1102.
  • Drummond MF. Future prospects for pharmacoeconomics and outcomes research in the emerging regions. Value in Health Regional Issues May 2013;2(1):3-4.
  • Drummond MF, Daniel Mullins C. Improving the quality of papers published in pharmacoeconomics and outcomes research. Value in health 2013;16(2):229-30.
  • Drummond MF, Shemilt I, Vale L, On behalf of the Campbell and Cochrane Economic Methods group. Should the Cochrane Collaboration be producing reviews of efficiency? Cochrane Database Syst Rev 2013 October 24;10: ED000071
  • Drummond MF, Tarricone R, Torbica A. Assessing the added value of health technologies: reconciling different perspectives. Value in Health 2013;16(1):S7-S13.
  • Eaton J, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Core A, Hontelez JAC, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Barnighausen T, Bershteyn A, Bloom DE, Boiley M-C, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, can de Vijer DAMC, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Vassell A, Doherty M, Shaffer N, Easterbrook P, Hirnschall G, Hallett TB. How Should HIV Programmes Respond to Evidence for the Benefits of Earlier ART Initiation? A Combined Analysis of Twelve Mathematical Models. Report for the Consolidated Clinical and Programmatic ART Guidelines Committees, HIV Department of the World Health Organizations 2013;WHO/HIV:2013.56. Download from WHO
  • Edlin R, McCabe C, Round J, Wright J, Claxton K, Sculpher M, Cookson R. Understanding Harris’ understanding of CEA: is cost effective resource allocation undone? Journal of Health Services Research and Policy 2013;18(1)(1):34-9.
  • Eldabe S, Raphael J, Thompson S, Manca A, deBelder M, Aggarwal R, Banks M, Morag B, Merotra S, Adeniba R, Davies E, Taylor R.S. The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): study protocol for a pilot randomised controlled trial. Trials 2013;15(57).
  • Epstein D, Mochón LG, Espín J, Soares MO. Use of multi-parameter evidence synthesis to assess the appropriateness of data and structure in decision models. Medical Decision Making 2013;33(5):715-730. Download from sagepub
  • Essat M, Faria R, Gomersall T, Grimm S, Keetharuth A, Walker S, Dixon S, Palmer S, Sculpher M (2014). Getting cost-effective technologies into practice: the value of implementation. Initial scoping review for phase 1. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU)2014; Research Report 005:pp172. Download from EEPRU
  • Faria R, Bojke L, Epstein D, Corbacho B, Sculpher M, On the behalf of the REFLUX trial group. Cost-effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of the REFLUX trial. British Journal of Surgery 2013;100(9):1205-1213.
  • Faria R, Manca A. Statistical analysis of clinical trial data for resource allocation decisions. In:Durlauf SN, Blume LE. (eds). The New Palgrave Dictionary of Economics Online. Palgrave;Macmillan 2013.
  • Faria R, McKenna C, Wade R, Yang H, Woolacott N, Sculpher M. The EOS 2D/3D X-ray imaging system: A cost-effectiveness analysis quantifying the health benefits from reduced radiation exposure. European Journal of Radiology 2013;82(8):e342-e349.
  • Faria R, Spackman E, Burch JA, Corbacho Martin MB, Todd D, Pepper C, Woolacott NF, Palmer S. Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: a NICE single technology appraisal. Pharmacoeconomics 2013;31(7):551-562.
  • Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini F. Transparency or proper study valuation procedures missed? Medical Care 2013;51(4):374-378.
  • Fischer A, Threlfall A, Meah S, Cookson R, Rutter R, Kelly M. The appraisal of public health interventions: Overview. Journal of Public Health 2013;35(4):488-494.
  • Grant A, Boachie C, Cotton S, Faria R, Bojke L, Epstein D, Ramsay C, Corbacho B, Sculpher M, Krukowski Zh, Heading R, Campbell M. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technology Assessment 2013;17(22).
  • Grant A, Cotton SC, Boachie C, Ramsay C, Krukowski ZH, Headling RC, Campbell MK, The REFLUX Trial Group (CHE members Bojke L, Faria R, Sculpher M,) Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 2013;346:f1908.
  • Gray R, Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Salazar-Vizcaya L, Hallett T. The Cost and Impact of Alternative Strategies for Monitoring Child Patients on ART. Report for the Consolidated Clinical and Programmatic ART Guidelines Committees, the HIV Department of the World Health Organizations 2013;WHO/HIV:2013.60. Download from WHO.
  • Grutters JPC, Sculpher MJ, Briggs AH, Severens JL, Candel MJ, Stahl SE, De Ruyssche D, Boer A, Ramaekers BLT, Joore MA. Acknowledging patient heterogeneity in economic evaluation.  A systematic literature review.Pharmacoeconomics 2013;31(2)(2):111-23.
  • Gutacker N, Bojke C, Daidone S, Devlin N, Street A. Hospital variation in patient-reported outcomes at the level of EQ-5D dimensions - Evidence from England. Medical Decision Making 2013;33(6):804-818.
  • Gutacker N, Bojke C, Daidone S, Devlin N, Parkin D, Street A. Truly inefficient or providing better quality of care? analysing the relationship between risk-adjusted hospital costs and patients' health outcomes. Health Economics 2013;22(8). Download from wiley
  • Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Purohit S, Rees D, Tillyer L, Walker I, Fijnvandraat K, Kirby-Allen M, Spackman E, Davies S, Williamson L.  The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised controlled multi-centre clinical trial. The Lancet 2013;381(9870):930-938.
  • Husereau D, Drummond M, Petrou S, Carswell C, Mother D, Greenberg D, Augustovski  F, Briggs AH, Mauskopf  J, Loder E.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. British Medical Journal 2013;Mar25:346.f1049.
  • Husereau D, Drummond M, Petrou S, Carswell C, Mother D, Greenberg D, Augustovski  F, Briggs AH, Mauskopf  J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)  - explanation and elaboration: A report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value in Health 2013;16(2):231-250.
  • Jacobs R, Mannion R, Davies HTO, Harrison S, Konteh F, Walshe K. The relationship between organizational culture and performance in acute hospitals. Social Science and Medicine 2013;76:115-25. Download from Sciencedirect
  • Jones AM, Laporte A, Rice N, Zucchelli E. Do smoking bans have an impact on active smoking? A model with evidence from a policy experiment in the UK. Health Economics 2013;doi: 10.1002/hec.3009.
  • Jones A M, Lomas J, Moore P, Rice N.  A quasi-Monte Carlo comparison of developments in parametric and semi-parametric regression methods for heavy tailed and non-normal data: with an application to healthcare costs. Health Economics and Data Group (HEDG), University of York 2013;working paper 13/30. Download from HERC
  • Jones AM, Lomas J, Rice N. Applying beta-type size distributions to healthcare cost regressions. Journal of Applied Econometrics 2013;doi:10.1002/jae.2334. Download from wiley
  • Kearns B, Ara R, Wailoo A, Manca A, Hernandez Alava M, Abrams K, Campbell M. Good practice guidelines for the use of statistical regression models in economic evaluation. Pharmacoeconomics 2013;31(8):643-652.
  • Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, Cambiano V, Ciaranello A, Estill J, Gray R, Hill A, Keiser O, Kessler J, Menzies NA, Nucifora KA, Salazar-Vizcaya L, Walker S, Welte A, Easterbrook P, Doherty M, Hirnschall G, Hallett T. How Should HIV Programmes Monitor Adults on ART? A Combined Analysis of Three Mathematical models. Report for the Consolidated Clinical and Programmatic ART Guidelines Committees, the HIV Department of the World Health Organizations. 2013;WHO/HIV:2013.61. Download from WHO
  • Kennedy A, Bower P, Reeves D, Blakeman T, Bowen R, Chew-Graham C, Eden M, Fullwood C, Gaffney H, Gardner C, Lee V, Morris R, Protheroe J, Richardson G, Sanders C, Swallow A, Thompson D, Rogers, A. Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. British Medical Journal 2013;346:f2882.
  • Lensberg B, Drummond MF, Danchenko N, Despiégel N, François C. Challenges in measuring and valuing productivity costs, and their relevance in mood disorders. ClinicoEconomics and Outcomes Research 2013;5:565-573.
  • Longworth L, Youn J, Bojke L, Palmer S, Griffin S, Spackman E, Claxton, K. When does NICE recommend the use of Health technologies within a programme of evidence development? : A systematic review of NICE guidance. Pharmacoeconomics 2013;31(2):137-49.
  • Mabugu T, Revill P, Van den Berg B. The methodological challenges for the estimation of quality of life in children for use in economic evaluation in low income countries. Value in Health Regional Issues 2013;2(2):231-239.
  • MacPherson H, Richmond S, Bland M, Brealey S, Gabe R, Hopton A, Keding A, Lansdow H,  Perren S, Sculpher M, Spackman E,  Torgerson D, Watt I.  Acupuncture and counselling for depression in primary care: a randomised controlled trial.  PLoS Medicine 2013;10(9):e1001518. Download from plosmedicine
  • Marks L, Weatherly HLA, Mason A. Prioritizing investment in public health and health equity: what can commissioners do? Public Health 2013;127(5):410-418.
  • Mason A, Mason JM, Cork M, Hancock H, Dooley G. Topical Treatments for chronic plaque psoriasis of the scalp: a systematic review. British Journal of Dermatology 2013;169(3):519-527.
  • Mason A, Mason JM, Cork M, Dooley G, Hancock H. Topical treatments for chronic plaque psoriasis. Cochrane database of systematic reviews (Online). 2013 Mar 28;(3)Art.No.:CD005028.
  • Mason A, Mason JM, Cork M, Hancock H, Dooley G. Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review. Journal of the American Academy of Dermatology 2013:69(5):799-807.
  • Moran V, Jacobs R. An international comparison of efficiency of inpatient mental health care systems. Health Policy 2013;112(1):88-99. Download from Elsevier
  • Naci H, Spackman E. National approaches to comparative effectiveness research. In: Handbook of Health Services Research. Springer 2013.
  • Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation. Health Technology Assessment 2013;17(52):1–342.
  • Norman R, Church J, van den Berg B, Goodall S. Australian health-related quality of life population norms derived from the SF-6D. Australian and New Zealand Journal of Public Health 2013;37(1)(1):17-23.
  • Olsen KR, Gyrd-Hansen D, Højmark TB, Kristensen T, Vedsted P, Street A. Organisational determinants of production and efficiency in General Practice. A population based study. European Journal of Health Economics 2013:14(2):267-276. Download from Springer
  • Owen-Jones E, Bekkers MJ, Butler C, Cannings-John R, Channon S, Hood K, Gregory J, Kemp A, Kenkre J, Martin Corbacho B, Montgomery A, Moody G, Pickett K, Richardson G, Roberts Z, Ronaldson S, Sanders J, Stamuli E, Torgerson D, Robling M, The effectiveness and cost-effectiveness of the Family Nurse Partnership home visiting programme for first time teenage mothers in England: a protocol for the Building Blocks randomised controlled trial. BMC Pediatrics 2013;13(114).
  • Pattenden J, Mason A, Lewin B. Collaborative palliative care for advanced heart failure: outcomes and costs from the 'Better Together' pilot study. BMJ Supportive and Palliative Care 2013;3(1):69-76.
  • Pitman R, Nagy LD, Sculpher MJ.  Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model. Vaccine 2013;31(6):927-42.
  • Revill P, Ryan P, McNamara A, Normand C. A cost and outcomes analysis of alternative models of care for young children with severe disabilities in Ireland. ALTER The European Journal of Disability Research 2013;7(4):260-274.
  • Richardson G, Epstein D, Chew-Graham C, Dowrick C, Bentall RP, Morriss RK, Peters S, Riste L, Lovell K, Dunn G, Wearden AJ. Cost-effectiveness of supported self-management for CFS/ME patients in primary care. BMC Fam Pract 2013;14(12).
  • Rudmik L, Drummond M. Health economic evaluation: Important principles and methodology. Laryngoscope 2013;123(6):1341-1347.
  • Ryan P, Revill P, Devane D, Normand C. An assessment of the cost-effectiveness of midwife-led care in the United Kingdom Midwifery 2013;29(4):368-376. Download from sciencedirect
  • Sampson C, Whitehurst D, Street AD. Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. European Journal of Health Economics 2013;14(4):703-705.
  • Schmitt LHM, Brugere C. Capturing ecosystem services, stakeholders’ preferences and trade-offs in coastal aquaculture decisions: a bayesian belief network application. PLoS ONE 2013;8(10):e75956.
  • Sculpher MJ. Methods development for health technology assessment: is it time to set priorities? Medical Decision Making 2013;33(3):313-5. Download from sagepub
  • Shah K, Cookson R, Culyer AJ, Littlejohns P. NICE’s social value judgements about equity in health and health care. Health Economics, Policy and Law 2013;8(2):145-65. Download from Cambridge journals
  • Shemilt I, McDaid D, Marsh K, Henderson C, Bertranou E, Mallander J, Drummond MF, Mugford M, Vale L. Issues in the incorporation of economic perspectives and evidence into Cochrane reviews. Systematic Reviews 2013 Sep 20;2(83):10.1186/2046-4053-2-83.
  • Siciliani L, Moran V, Borowitz M. Measuring and comparing health care waiting times in OECD countries. OECD Health Working Papers 2013;No.67:OECD Publishing.
  • Siciliani L, Sivey P, Street A. Differences in length of stay for hip replacement between public hospitals, specialised treatment centres and private providers: selection or efficiency? Health Economics 2013;22(2):119-131.
  • Smith PC, Street AD. On the uses of routine patient-reported health outcome data. Health Economics 2013;22(2):119-131.
  • Soares MO, Dumville J, Ashby RL, Iglesias Urrutia CP, Bojke L, Adderley UJ, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: Negative-pressure wound therapy for severe pressure ulcers. Medical Decision Making 2013;33(3):415-36.
  • Sorenson C, Drummond MF, Bhuiyan Khan B. Medical technology as a key driver of rising health expenditures: disentangling the relationship. ClinicoEconomics and Outcomes Research 2013;5:223-234.
  • Sorenson C, Drummond MF, Burns LR. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. Health affairs (Project Hope) 2013 April;32(4):788-796.
  • Sorenson C, Drummond MF, Wilkinson G. Use of innovation payments to encourage the adoption of new medical technologies in the English NHS. Health Policy and Technology 2013;2(3):168-173.
  • Spackman E. The significance and international influence of NICE.  The Economic Evaluation of Health technology and Public policy - the case from overseas and the course of Japan. Tokyo, Japan: Jiho; 2013.
  • Spackman E, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. The validity of dependence as a health outcome measure in Alzheimer disease.  American Journal of Alzheimer's Disease & Other Dementias 2013;28(3):245-252.
  • Spackman E, Rice S, Norman G, Suh D-C, Eastwood A, Palmer S. Trastuzumab for the treatment of HER2-positive metastatic gastric cancer:A NICE single technology appraisal. Pharmacoeconomics 2013;31(3):185-194.
  • Spackman E, Sculpher M, Howard J, Malfroy M, Llewelyn C, Choo L,  Hodge R, Johnson T, Rees D, Fijnvandraat K, Kirby-Allen M, Davies S, Williamson L. Cost effectiveness analysis of pre-operative transfusion in patients with sickle cell disease using evidence from the TAPS trial. European Journal of Haematology  2013;doi:10.1111/ejh.12232.
  • Spinner D, Birt J, Walter J, Bowman LLB, Mauskopf J, Drummond M, Copley-Merriman C. Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions. ClinicoEconomics and Outcomes Research 2013;5:69-85.
  • Street A. An overview of competition in UK health care. In: Competition in UK health care: reflections on an expert workshop. Eds. Charlesworth A, Kelly E. Institute for Fiscal Studies and Nuffield Trust research report, December 2013.
  • Tsoi B, Masucci L, Campbell K, Drummond MF, O'Reilly D, Goeree R. Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences. Expert Review of Pharmacoeconomics and Outcomes Research 2013;13(4):497-511.
  • Van Dijk CE, Van den Berg B, Verheij RA, Spreeuwenberg P, Groenewegen PP, De Bakker DH. Moral hazard and supplier-induced demand: empirical evidence in general practice. Health Economics 2013;22(3):340-352.
  • Wade R, Spackman E, Corbett M, Walker S, Light K, Naik R, Sculpher M, Eastwood A. Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS, LuViva advanced cervical scan and niris imaging system. Health Technology Assessment 2013;17(8). Download from HTA.
  • Walker S, Girardin F, McKenna C, Ball SG, Nixon J, Plein S, Greenwood JP, Sculpher M. Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 2013;99(12):873-81.

2012/2011

2012

  • Allen P, Keen J, Wright J, Dempster PG, Townsend J, Hutchings A, Street A, Verzulli R. Investigating the governance of autonomous public hospitals in England: multi-site case study of NHS Foundation Trusts. Journal of Health Services Research and Policy 2012;17(2):94-100. Download from Sage
  • Ashby R, Dumville J, Soares M, McGinnis E, Stubbs N, Torgerson D, Cullum N. A pilot randomised controlled trial of negative pressure wound therapy (NPWT) to treat grade III/IV pressure ulcers. Trials 2012;13(119). Download from trialsjournal
  • Basu A, Manca A. Regression estimators for generic health-related quality of life and quality-adjusted life years. Medical Decision Making 2012;32(1):56-69.
  • Bojke L, Spackman E, Hinde S, Helliwell P. Capturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity. Rheumatology 2012;51(2):210-15.
  • Bower P, Kennedy A, Reeves D, Richardson G. A cluster randomised controlled trial of the clinical and cost-effectiveness of a “whole-systems” model of self management support for the management of long term conditions in primary care:trial protocol. Implementation Science 2012;7:7(January).
  • Briggs AH, Weinstein MC, Fenwick E, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: A report of the ISPOR-SMDM Modelling Good Research Practices Task Force Working Group-6. Medical Decision Making 2012;32(5):722-32.
  • Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD. on behalf of the ISPOR-SMDMK Modelling Good Research Practices Task Force (2012).  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modelling Good Research Practices Task Force-6. Value in Health 2012;15(6):835-42.
  • Brown S, Ortiz-Nuñez A, Taylor K. Parental risk attitudes and children’s academic test scores: evidence from the U.S. panel study of income dynamics. Scottish Journal of Political Economy 2012;59(1):47-70.
  • Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children Aged 6-11 years: a NICE single technology appraisal. Pharmacoeconomics 2012;30(11):991-1004. Download from springer
  • Burch J, Hinde S, Palmer S, Beyer F, Minton J, Marson A, Wieshmann U, Woolacott N, Soares M. The clinical and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model. Health Technology Assessment 2012;16(34). Download from NIHR
  • Burch J, Marson A, Beyer F, Soares M, Hinde S, Wieshmann U, Woolacott N. Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery. Epilepsia 2012;53(8):1294-302. Download from wiley 
  • Burton C, Richardson G, Sharpe M. Healthcare costs incurred by repeated referral of patients with medically unexplained symptoms to secondary medical care. Journal of Psychosomatic Research 2012;72(3):242-247.
  • Cabieses B, Espinoza M. The power of chameleonic ideas in the policy decision-making process: the case of the 'students' revolution' in Chile. Journal of Education for Teaching: International research and pedagogy 2012;38(4):509-11.
  • Chuang LH, Soares MO, Tilbrook H, Cox H, Hewitt CE, Aplin J, Semlyen A, Trewhela A, Watt I, Torgerson D. A pragmatic multi-centered randomised controlled trial of yoga for chronic low back pain: economic evaluation Spine 2012;37(18):1593-1601.
  • Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman DE, Youn J. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technology Assessment 2012;16(46). Download from NIHR
  • Conigliani C, Manca A, Tancredi A. Statistical methods for health care economic evaluation. In: Faltin F, Kenett R, Ruggeri F, editors. Statistical Methods in Healthcare:Wiley;2012:Chapter 18.
  • Cookson R, Claxton K. The humble economist. Tony Culyer on health, health care and social decision making. Office of Health Economics, London and University of York, 2012. 
  • Cookson R, Dawson D. Hospital competition and patient choice in publicly funded health care. In: Jones AM, editor. The Elgar Companion to Health Economics (2 nd Edition) Cheltenham: Edward Elgar;2012.
  • Cookson R, Laudicella M, Li Donni P. Measuring change in health care equity using small area administrative data – evidence from the English NHS 2001-8. Social Science and Medicine 2012;75(8):1514-1522.
  • Cookson R, Laudicella M, Li Donni P, Dusheiko M. Effects of the Blair/Brown health reforms on socioeconomic equity in health care. Journal of Health Services Research and Policy 2012;17(Suppl1):55-63.
  • Cooper NJ, Kendrick D, Achana F, Dhiman P, He Z, Wynn P, Le Cozannet E, Saramago P, Sutton A. Network meta-analysis to evaluate the effectiveness of interventions to increase the uptake of smoke alarms. Epidemiologic Reviews 2012;34(1):32-45.
  • Costa-Font J, Karlsson M, Van den Berg B. Redesigning long-term care finance and delivery. Applied Economic Perspectives and Policy 2012;34(2):215-19.
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • Culyer AJ. Hic sunt dracones: the future of Health Technology Assessment - one economist's perspective. Medical Decision Making 2012;32:E25-E32.
  • Daidone S, Street A. Specialisation hierarchy within the Children’s Specialised Services National Definition Set. Report to Department of Health, Economics of Social and Health Care Research Unit, University of York; 2012. Download from eshcru
  • Drummond MF. Economic evaluation and decision makers In: Jones AM, editor. The Elgar Companion to Health Economics. Cheltenham: Edward Elgar;2012:p.640.
  • Drummond M, Neumann P, Jonsson B, Luce B, Schwartz J, Siebert U, Sullivan S. Can we reliably benchmark health technology assessment organizations? International Journal of Technology Assessment in Health Care 2012;28(2):159-65.
  • Drummond MF, Towse A. Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe? European Journal of Health Economics 2012;13:1-5.
  • Dumville JC, Soares MO, O'Meara S, Cullum N. Systematic review and mixed treatment comparison: Dressings to heal diabetic foot ulcers. Diabetologia 2012;55(7):1902-1910. Download from springerlink
  • Faria R, Weatherly H, Van den Berg B. A review of approaches to measure and monetarily value informal careBerg. In: Curtis L, editor. Unit costs of health and social care 2012. Kent: PSSRU; 2012. p. 22-31
  • Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond MF, Jonsson B, Scambia G, Zweifel P, Mennini F. Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases. The BEST study. Medical Care 2012;50(12):1076-85.
  • Fleetcroft R, Steel N, Cookson R, Walker S, Howe A. Incentive payments are not related to expected health gain in the pay for performance scheme for UK primary care: cross-sectional analysis. BMC Health Services Research 2012;12(94). Download from biomedcentral
  • Ford JA, Waugh N, Sharma P, Sculpher MJ, Walker A. NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium. BMJ Open 2012;2(1):e000671. Download from bmjopen
  • Garber AM, Sculpher M. Cost-effectiveness and payment policy. In: Pauly MV, McGuire TG, Barros PP, editors. Handbook in Health Economics. Oxford: Elsevier; 2012.
  • Gaughan J, Kobel C, Linhart C, Mason A, Street A, Ward P. Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across ten European countries. Health Economics 2012;21(S2):77-88. Download from wiley
  • Howdon D. Time and chance happen to them all? duration modelling versus lifetime incidence of cancer. Health Economics and Data Group (HEDG), University of York 2012;working paper 12/06. Download from HEDG
  • Jones AM, Rice N, Bago d'Uva T, Balia S. Applied Health Economics (Second Edition). London: Routledge, 2012. 
  • Jones AM, Rice N, Contoyannis PC. The dynamics of health. In: Jones AM, editor. Elgar Companion to Health Economics (second Edition). Cheltenham: Edward Elgar; 2012.
  • Jones AM, Rice N, Robone S. A comparison of parametric and non-parametric adjustments using vignettes for self-reported data. Health Economics and Data Group (HEDG), University of York 2012;12/10. Download from HERC
  • Jones AM, Rice N, Rosa-Dias P. Quality of schooling and inequality of opportunity in health. Empirical Economics 2012;42(2):369-394.
  • Joyce VR, Barnett PG, Chow A, Bayoumi AM, Griffin S, Sun H, Holodniy M, Brown ST, Kyriakides TC, Cameron DW, Youle M, Sculpher M, Anis AH, Owens DK. Effect of treatment interruption and intensification of antiretroviral therapy on health related quality of life in patients with advanced HIV: a randomized, controlled trial. Medical Decision Making 2012;32(1):70-82. Download from sagepub
  • Kontopantelis E, Doran T, Gravelle H, Siciliani L, Sutton M, Goudie R. Pay-for-performance and influenza immunization: the impact of raising the bar in the UK Quality and Outcomes Framework. Health Services Research 2012;47(3, part 1):1117-36.
  • Laudicella M, Siciliani L, Cookson R. Waiting times and socioeconomic status: evidence from England. Social Science and Medicine 2012;74(9):1331-41.
  • Luce B, Drummond MF. Principles for the conduct of comparative effectiveness research. Journal of Comparative Effectiveness Research 2012;1(5):431-40.
  • Manca A, Asseburg C, Bravo-Vergel Y, Seymour MT, Meade A, Stephens R, Parmar M, Sculpher MJ. The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS). Value in Health 2012;15(1):22-31.
  • Martin R, Muûls M, de Pruex L, Wagner U. Anatomy of a paradox: management practices, organizational structure and energy efficiency. Journal of Environmental Economics and Management 2012;63(2):208-223.
  • Martin S, Rice N, Smith PC. Comparing costs and outcomes across programmes of healthcare. Health Economics 2012;21(3):316-337.
  • Mason A, Or Z, Renaud T, Street A, Thuilliez J, Ward P. How well do DRGs for appendectomy explain variations in resource use? An analysis of patient-level data from 10 European countries. Health Economics 2012;21(S2):30-40. Download from wiley
  • Maund E, Craig D, Suekarran S, Neilson AR, Wright K, Brealey S, Dennis L, Goodchild L, Hanchard N, Rangan A, Richardson G, Robertson J, McDaid C. Management of frozen shoulder: a systematic review and cost-effectiveness analysis. HTA Report 09/13/02 2012.
  • McKenna C, Maund E, Sarowar M, Fox D, Stevenson M, Pepper C, Woolacott N, Palmer S. Dronedarone for the treatment of atrial fibrillation. A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:35-46.
  • McKenna C, Wade R, Faria R, Yang H, Stirk L, Gummerson N, Sculpher M, Woolacott N. EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation. Health Technology Assessment 2012;16(14):1-188. Download from HTA
  • McKenna C, Walker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Palmer S. Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure. Value in Health 2012;15(3). More details  from Value in Health
  • Miraldo M, Siciliani L, Street A. Price adjustment in the hospital sector, Reply. Journal of Health Economics 2012;31(1):323-25.
  • Mujica-Mota RE, Tarricone R, Ciani O, Bridges JFP, Drummond MF. Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Services Research 2012;12(1).
  • O'Reilly J, Busse R, Häkkinen U, Or Z, Street A, Wiley M. Paying for hospital care: the experience with implementing activity-based funding in five European countries. Health Economics Policy and Law 2012;7(1):73-101.
  • Pichon-Riviere A, Augustovski F, Marti SG, Sullivan SD, Drummond MF. Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers. International Journal of Technology Assessment in Health Care 2012;28(2):180-86.
  • Pitman RL, White LJ, Sculpher MJ. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine 2012;30:1208-24.
  • Revill P, Sculpher MJ. Cost effectiveness of interventions to tackle non-communicable diseases. British Medical Journal 2012;344:d7883. Download from bmj
  • Rodgers M, Asaria M, Walker S, McMillan D, Lucock M, Harden M, Palmer S, Eastwood A. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technology Assessment 2012;16(28):1-129. Download from HTA
  • Rice N, Robone S, Smith P. Vignettes and health systems responsiveness in cross-country comparative analyses. The Journal of the Royal Statistical Society A 2012;175(2):1-21.
  • Saramago P, Manca A, Sutton AJ. Deriving input parameters for cost-effectiveness modelling: taxonomy of data types and approaches to their statistical synthesis. Value in Health 2012;15(5):639-649.
  • Saramago P, Sutton A, Cooper NJ, Manca A. Mixed treatment comparisons using aggregate-and individual-participant level data statistics in medicine Statistics in Medicine 2012;doi:10.1002.sim.5442.
  • Schut FT, Van den Berg B. Long-term care insurance in the Netherlands. In: Costa-Font J, Courbage C, editors. Financing Long-Term Care in Europe: Palgrave; 2012.
  • Sculpher M, Claxton K. Real economics needs to reflect real decisions:A response to Johnson. PharmacoEconomics 2012; 30(2):133-136. Download from springer
  • Smith PC, Street A. Concepts and challenges in measuring the performance of health care organizations. In: Jones A, editor. Elgar Companion to Health Economics: Second Edition: Edward Elgar, Cheltenham; 2012. p.341-49.Further details
  • Smith PC, Street A. On the uses of routine patient-reported health outcome data. Health Economics 2012;22(2):119-131.
  • Soares MO. Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity. British Medical Bulletin 2012;101(1):17-31. Download from oxfordjournals
  • Soares MO, Canto e Castro L. Continuous time simulation and discretized models for cost-effectiveness analysis. Pharmacoeconomics 2012;30(12):1101-17. Download from springer
  • Soares MO, Dumville J, Ashby R, Iglesias C, Bojke L, Adderley U, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: negative pressure wound therapy for severe pressure ulcers. Medical Decision Making 2012;doi:10.1177/0272989X12451058. Download from sagepub
  • Soares MO, Welton NJ, Harrison DA, Peura P, Hari MS, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Rowan KM. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technology Assessment 2012;16(7).
  • Sorenson C, Drummond MF. Socio-economic value of orthopedic devices: evidence and methodological challenges. Orthopedic Research and Reviews 2012;4:87-96.
  • Sorenson C, Drummond MF, Chalkidou K. Comparative effectiveness research: the NICE experience. Journal of Clinical Oncology 2012;30(34).
  • Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. Measuring alzheimer disease progression with transition probabilities: estimates from NACC-UDS. Current Alzheimer Research 2012;9(9):1050-58.
  • Street A, Kobel C, Renaud T, Thuilliez J. How well do Diagnosis Related Groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data. Health Economics 2012;S21:6-18. Download from wiley
  • Thwaites G, Auckland C, Barlow G, Cunningham R, Davies G, Edgeworth J, Greig J, Hopkins S, Jeyaratnam D, Jenkins N, Llewelyn M, Meisner S, Nsutebu E, Planche T, Read RC, Scarborough M, Soares MO, Tilley R, Török ME, Williams J, Wilson P, Wyllie S, Walker AS. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial. Trials 2012;13:241. Download from trials journal
  • Towse A, Drummond MF, Sorenson C. Measuring value:pharmacoeconomics theory and practice. In: Danzon P, Nicholson S, editors. The Oxford Handbook of The Economics of the Biopharmaceutical Industry. Oxford: Oxford University Press; 2012. p.394-437.
  • Van den Berg B. SF-6D population norms. Health Economics 2012;21(12):1508-1512.
  • Wade R, Yang H, McKenna C, Faria R, Gummerson N, Woolacott N. A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system. European Spine Journal 2012;DOI 10.1007/s00586-012-2469-7.
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. Journal of Health Economics 2012;31:406-39.
  • Walker S, Griffin S, Claxton K, Palmer S, Sculpher M. Guest editorial, Appropriate perspectives for health care decisions. In: Curtis L, editor. Unit costs of health and social care 2012. Kent: PSSRU; 2012. p. 8-11. Download from pssru
  • Walker S, Sculpher M, Claxton K, Palmer S. Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions. Value in Health 2012;15(3)570-579. More details from Value in Health
  • Wang S, Chalkley M, Tilley C. Comparing the treatment provided by UK and non-UK trained health professionals: dentists in Scotland. Health Services Research & Policy 2012;17(4):227-232. Download from sage journals
  • Wasi N, Van den Berg B, Buchmueller T. Heterogeneous effects of child disability on maternal labor supply: evidence from the 2000 US census. Labour Economics 2012;19(1):139-154.
  • Yang H, Craig D, Epstein D, Bojke L, Light K, Bruce I, Sculpher M, Woolacott N. Golimumab for the treatment of psoriatic arthritis: A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:257-70.
  • Zucchelli E, Harris M, Zhao X. Ill-health and transitions to part-time work and self-employment among older workers. Health Economics and Data Group (HEDG), University of York 2012;working paper 12/04. Download from HERC
  • Zucchelli E, Jones AM, Rice N. The evaluation of health policies through dynamic microsimulation methods. International Journal of Microsimulation 2012;5(1):2-20.

2011

  • Asaria M, Norman G, Hinde S, O'Connor J, Palmer S, Light K, Soares M, Eastwood A. Fingolimod for the treatment of relapsing remitting multiple sclerosis. (PDF , 2,151kb). CRD/ CHE Technology Assessment Group, University of York, 2011.
  • Backhouse M, Wonder M, Hornby E, Kilburg A, Drummond MF, Mayer FK. Early dialogue between the developers of new technologies and pricing and reimbursement agencies. Value in Health 2011;14:608-15.
  • Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin S, Nosyk B, Holodniy M, Brown ST, Sculpher M, Anis AH, Owens DK. Determinants of the cost of health services used by veterans with HIV. Medical Care 2011;49(9):848-56.Download from pubmed
  • Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD. Review and meta-analysis of biomarkers and diagnostic imaging in alzheimer's disease. J Alzheimers Dis 2011;26(4).
  • Bloudek LM, Spackman DE, Veenstra DL, Sullivan SD. CDR state transition probabilities in alzheimer's disease with and without cholinesterase inhibitor intervention in an observation cohort J Alzheimers Dis 2011;24(3).
  • Bojke L, Epstein D, Craig D, Rodgers M, Woolacott N, Yang H, Sculpher M. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology 2011;50:iv39-iv47.
  • Brown S, Dietrich M, Ortiz-Nuñez A, Taylor K.  Self-employment and attitudes towards risk: timing and unobserved heterogeneity. Journal of Economic Psychology 2011;32:425-433.
  • Brown S, Ortiz-Nuñez A, Taylor K. What will I be when I grow up? an analysis of childhood expectations and career outcomes. Economics of Education Review 2011;30:493-506.
  • Burgess J, Street A. Measuring organisational performance. In: Smith PC, Glied SA, editors. The Oxford handbook of health economics. Oxford: Oxford University Press;2011.
  • Campbell HE, Epstein D, Bloomfield D, Griffin S, Manca A, Yarnold J, Bliss J, Johnson L, Earl H, Poole C, Hiller L, Dunn J, Hopwood P, Barrett-Lee P, Ellis P, Cameron D, Harris AL, Gray AM, Sculpher MJ. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer 2011;Nov 47(17):2517-30.Download from Sciencedirect
  • Carr-Hill R. A large-scale donor attempt to improve educational status of the poor and household income distribution; the experience of PEDC in Vietnam. International Journal of Educational Development 2011;31(3):251-61.
  • Castelli A, Laudicella M, Street A, Ward P. Getting out what we put in: productivity of the English NHS. Health Economics, Policy and Law 2011;6:313-335. Download from Cambridge Journals ©Cambridge Journals.
  • Chalkley M, Stewart G. Trade liberalisation, market structure and the incentive to merge. The World Economy 2011;34(8):1327-47.
  • Chase R, Culyer AJ, Dobrow M, Coyte P, Sawka C, O'Reilly S, Laing K, Trudeau M, Smith S, Hoch J, Morgan S, Peacok S, Abbott R, Sullivan T. Access to cancer drugs in Canada: looking beyond coverage decisions. Healthcare Policy 2011;6:27-35.
  • Chuang LH, Soares MO, Watson JM, Bland JM, Cullum N, Iglesias C, Kang'ombe AR, Torgerson D, Nelson EA, on behalf of the VenUS III team. Economic evaluation of a randomized controlled trial of ultrasound therapy for hard-to-heal venous leg ulcers. British Journal of Surgery 2011;98(8):1099-1106. Download from Wiley
  • Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health care technologies. Health Economics 2011;20(1):2-15. Download from Wiley
  • Cookson R. The tough test for the NHS isn’t cost but care. Parliamentary Brief 2011;13(6).
  • Cookson R, Laudicella M. Effects of Health Reform on Health Care Inequalities - Final Report. NIHR SDO Programme - London 2011.
  • Culyer AJ. Maximising the odds. New Statesman (supplement: Competition in a New Society: National Health) 2011;15 December 6-8.
  • Culyer AJ. UK report: NHS 'reforms: Health Care Cost Monitor 1-2, The Hastings Center; 2011.
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • de Preux L. Anticipatory ex ante moral hazard and the effect of medicare on prevention. Health Economics 2011;20(9):1056-72.
  • Dixon J, Smith PC, Gravelle H, Martin S, Bardsley M, Rice N, Georghiou T, Dusheiko M, Billings J, De Lorenzo M, Sanderson C. A person based formula for allocating commissioning funds to general practices in England: development of a statistical model. British Medical Journal 2011;DOI: 10.1136/bmj.d6608.
  • Drummond MF, Augustovski F, Melendez G, Lemgruber A. Implementing pharmacoeconomic guidelines in Latin America: lessons learned. Value in Health 2011;14:S3-S7.
  • Drummond MF, Jönsson B, Rutten F, Stargardt T. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. The European Journal of Health Economics 2011;12:263-71.
  • Dusheiko M, Doran T, Gravelle H, Fullwood C, Roland M. Does higher quality of diabetes management in family practice reduce unplanned hospital admissions? Health Services Research 2011;46:27-46.
  • Dusheiko M, Gravelle H, Martin S, Rice N, Smith PC. Does disease management in primary care reduce hospital costs? Evidence from English primary care. Journal of Health Economics 2011;30(5):919-32.
  • Elston J, Santaniello-Newton A, Meigh J, Harmer D, Allgar V, Allison T, Richardson G, Meigh R, Palmer SR, Barlow G. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake- surveillance in Hull and East Yorkshire, United Kingdom, 2002-2009. Epidemiology and Infection 2011;DOI:10.1017/S0950268811001907.
  • Epstein D, Sutton A. Modelling correlated clinical outcomes in health technology appraisal. Value in Health 2011;14(6):793-99.Download from Value in Health
  • Felix J, Andreozzi V, Soares M, Borrego P, Gervasio H, Moreira A, Costa L, Marcelo F, Peralta F, Furtado I, Pina F, Albuquerque C, Santos A, Passos-Coelho JL. For the Portuguese group for the study of bone metastases. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: An estimation for the Portuguese National Health System. Value in Health 2011;14(4).
  • Fleetcroft R, Cookson R, Steel N, Howe A. Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis. British Journal of General Practice 2011;61:554-55.
  • Garau M, Shah K, Mason A, Wang Q, Towse A, Drummond M. Using QALYs in cancer: a review of the methodological limitations. Pharmacoeconomics 2011;29(8):673-85.
  • Goudie R, Goddard M. Review of evidence on what drives economies of scope and scale in the provision of NHS services, focusing on A & E and associated hospital services. Report for the OHE Commission on Competition in the NHS. London: Office of Health Economics;2011. Download from OHE
  • Gravelle H, Hole AR, Santos R. Measuring and testing for gender discrimination in physician pay: English family doctors. Journal of Health Economics 2011;30(4):660-74.
  • Griffin S, Claxton K. Analysing uncertainty in cost-effectiveness for decision making. In: Glied S, Smith PC, editors. Oxford Handbook of Health Economics. Oxford: Oxford University Press; 2011.
  • Griffin S, Claxton K, Palmer S, Sculpher M. Dangerous omissions: the consequences of ignoring decision uncertainty. Health Economics 2011;20:212-24.
  • Harrison M, Bansback N, Marra C, Drummond MF, Tugwell B. Valuing health for clinical and economic decisions: directions relevant for rheumatologists. The Journal of Rheumatology 2011;38(8):1770-75.
  • Hassink WHJ, Van den Berg B. Time-bound opportunity costs of informal care: Consequences for access to professional care, caregiver support, and labour supply estimates. Social Science and Medicine. 2011;73(10):1508-16.
  • Hastrup LH, Van den Berg B, Gyrd-Hansen D. Do informal caregivers in mental illness feel more burdened? A comparative study of mental versus somatic illnesses. Scandinavian Journal of Public Health 2011;39:598-6-7.
  • Hawkins N, Richardson G, Sutton A, Cooper N, Griffiths C, Rogers A, Bower P. Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Economics 2011;DOI:10.1002/hec.1741.
  • Hvenegaard A, Nielsen Arendt J, Street A, Gyrd-Hansen D. Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? European Journal of Health Economics 2011;12:541-51.
  • Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. The attitudes of primary school children in Northern Thailand towards their peers who are affected by HIV and AIDS. Aids Care 2011;23:237-44.
  • Jackson CH, Bokje L, Thompson SG, Claxton K, Sharples LD. A framework for addressing structural uncertainty in decision models. Medical Decision Making 2011;31(4):662-674.Download from sagepub
  • Jacobs R, Barrenho E. The impact of crisis resolution and home treatment teams on psychiatric admission rates in England. British Journal of Psychiatry 2011;199(1):71-76.
  • Jones AM, Lomas J, Rice N. Applying beta-type size distributions to healthcare cost regressions. Health Econometrics and Data Group (HEDG),University of York 2011;11/31. Download from HERC  
  • Jones AM, Laporte A, Rice N, Zucchelli E. A model of the impact of smoking bans on smoking with evidence from bans in England and Scotland. Health Economics and Data Group (HEDG), University of York 2011;working paper 11/05.Download from HERC
  • Jones AM, Rice N, Rosa Dias P. Long-term effects of schooling quality on health and lifestyle: Evidence from comprehensive schooling reforms in England. Journal of Human Capital 2011;5(3):342-76.
  • Jones AM, Rice N, Robone S, Rosa-Dias P. Inequality and polarisation in health systems' responsiveness: a cross-country analysis. Journal of Health Economics 2011;30(4):616-25.
  • Kolosa K, Manca A, Schubert S. A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policy making processes in Poland. Health Policy 2011;102(2-3):145-151.
  • Longworth L, Sculpher M, Bokje L, Tosh J. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. International Journal of Technology Assessment in Health Care 2011;27(2):180-7.Download from pubmed
  • Mandalà M, Imberti G, Piazzalunga D, Belfiglio M, Di Biagio K, Robone S, Labianca R, Marchesi L, Merelli B, Poletti P, Milesi A, Milesi L, Tondini C. Socio-economic status and education grade influence Breslow thickness, disease free and overall survival in clinical stage I-II AJCC skin melanoma: outcome analysis from a single institution experience. Mayo Clinic Proceedings 2011;16(2).
  • Marks L, Cave S, Wallace A, Mason A, Hunter DJ, Mason JM, Peckham S. Incentivising preventive services in primary care: perspectives on the use of Local Enhanced Services. Journal of Public Health 2011; 33 (4): 556-564.
  • Martin M, Lensberg B, Drummond MF, McGuire A. Relative efficacy - towards a new frontier? ISPOR Connections 2011;17(5):8-10.
  • Mason A, Goddard M, Myers L, Verzulli R. Navigating uncharted waters? How international experience can inform the funding of mental health care in England. Journal of Mental Health 2011;20(3);234-48. Download from informa.
  • Mason A, Ward P, Street A. England: the Healthcare Resource Group system. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England: Open University Press;2011;p197-220.
  • Mauskopf JA, Walter J, Copley-Merriman K, Birt J, Bowman LLB, Drummond MF. Differences among formulary submission guidelines:implications for health technology assessment. International Journal of Technology Assessment in Health Care 2011;27(3):261-70.
  • Maynard A, Street A, Hunter R. Using ‘payment by results’ to fund the treatment of dependent drug users-proceed with care! Addiction 2011;106(10):1715-1882.
  • McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Medical Decision Making 2011;31:853-865.Download from Pubmed
  • Miraldo M, Siciliani L, Street A. Price adjustment in the hospital sector. Journal of Health Economics;30(1):112-125.
  • Morris S, Goudie R, Sutton M, Gravelle H, Elliott R, Hole A, Ma A, Sibbald B, Skatun D. Determinants of general practitioners’ wages in England. Health Economics 2011;20:147-60.
  • Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. Health Technology Assessment 2011;15(Suppl 1):33-42.
  • Paulden M, Claxton K. Budget allocation and the revealed social rate of time preference for health. Health Economics 2011;21(5):612-618. Download from Wiley
  • Powdthavee N, van den Berg B. Putting different price tags on the same health condition: Re-evaluating the well-being valuation approach. Journal of Health Economics 2011;30(5):1032-43.
  • Rice N, Robone S, Smith PC. Analysis of the validity of the vignette approach to correct for heterogeneity in reporting health system responsiveness. The European Journal of Health Economics 2011;12(2):141-62.
  • Robone S, Jones AM, Rice N. Contractual conditions, working conditions, health and well-being in the British Household Panel Survey. The European Journal of Health Economics 2011;12(5):429-44.
  • Robone S, Rice N, Smith P. Health systems` responsiveness and its characteristics: a cross-country comparative analysis. Health Services Research 2011;46(6):2079-100.
  • Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technology Assessment 2011;15(10):1-329. Download from HTA
  • Rodgers M, Soares M, Epstein D, Yang H, Fox D, Eastwood A. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health Technology Assessment 2011;15:Suppl.1.Download from HTA
  • Rogers A, Vassilev I, Sanders C, Kirk S, Chew-Graham C, Kennedy A, Protheroe J, Bower P, Blickem C, Reeves D, Kapadia D, Brooks H, Fullwood C, Richardson G. Social networks, work and network-based resources for the management of long-term conditions: a framework and study protocol for developing self-care support. Implementation Science 2011;6:56(May).
  • Sampat B, Drummond MF. Another special relationship? interactions between health technology policies and health care systems in the United States and the United Kingdom. Journal of Health Politics, Policy and Law 2011;36:119-39.
  • Soares MO, Bojke L, Dumville J, Iglesias C, Callum N, Claxton K. Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration. Statistics in Medicine 2011;30(19):2363-2380. Download from Wiley
  • Sorenson C, Tarricone R, Siebert M, Drummond MF. Applying health economics for policy decision making: do devices differ from drugs? Europace Spotlight Supplement 2011;13:ii54-ii58.
  • Star SM, Van den Berg B. Individual responsibility and health-risk behaviour: A contingent valuation study from the ex ante societal perspective. Health Policy 2011;101:300-311.
  • Street A, O'Reilly J, Ward P, Mason A. DRG-based hospital payment and efficiency: theory, evidence, and challenges. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire, England:Open University Press;2011:p93-114.
  • Sullivan PW, Slejko JF, Sculpher MJ. Catalogue of EQ-5D Scores for the United Kingdom. Medical Decision Making 2011;31(6):800-804.
  • Tarricone R, Drummond MF. Challenges in the clinical and economic evaluation of medical devices:The case of transcatheter aortic valve implantation. Journal of Medical Marketing 2011;11(3):221-29.
  • Towse A, Drummond MF, Sorenson C. Measuring value:pharmacoeconomics theory and practice. London: Office of Health Economics; 2011.
  • Tso P, Culyer AJ, Brouwers M, Dobrow MJ. Developing a decision aid to guide public sector health policy decisions: A study protocol. Implementation Science 2011;6(46).
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. World Bank Policy Research Working Paper Series 2011;5829.
  • Walker S, Burch J, McKenna C, Wright K, Griffin S, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: Health Technology Assessment 2011;15:Suppl.1:13-21.
  • Walker S, Sculpher M, Drummond MF. The methods of cost-effectiveness analysis to inform decisions about the use of health care interventions and programmes. In: Smith PC, Glied S, editors. Oxford Handbook of Health Economics. Oxford: Oxford University Press; 2011. p. 733-58.
  • Watson JM, Kang'ombe AR, Soares MO, Chuang LH, Worthy G, Bland JM, Iglesias C, Cullum N, Torgerson D, Nelson EA on behalf of the VenUS III Team. Use of weekly,low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial. BMJ 2011;342. Download from BMJ
  • Watson JM, Kang'ombe AR, Soares MO, Chuang LH, Worthy G, Bland JM, Iglesias C, Cullum N, Torgerson D, Nelson EA on behalf of the VenUS III team. A randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers. Health Technol Assess 2011;15(13):1-176. Download from HTA
  • Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2011;98:370-76.Download from BMJ
  • Weatherly H, Kirk S, Kyle RG, Callery P. Comparison of costs of acute care by children's community nursing teams Archives of Disease in Childhood 2011;96(Suppl 1):A92.

2010/2009

2010

  • Ashby R, Bland JM, Cullum N, Dumville J, Hall J, Kang'ombe A, Madden M, O'Meara S, Soares M, Torgerson D, Watson J. Reflections on the recommendations of the EWMA patient outcome group. Journal of Wound Care 2010;19(7):282-85. Download from Pubmed
  • Bailey H, Kind P. Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Quality of Life Research 2010;19(8):1145-54.
  • Barbieri M, Drummond M, Rutten F, Cook J, Glick H, Lis J, Reed SD, Sculpher M, Severens J. On behalf of the ISPOR good research practices economic data transferability task force. What do international pharmacoeconomic guidelines say about economic data transferability? Value in Health 2010;13:1028-37.
  • Bloudek L, Spackman DE, Sullivan SD. A comparison of transitions between health states and institutionalization among alzheimer's disease patients versus non-alzheimer's disease dementia patients using the nacc-uds database. Value in Health 2010;13(3):108-9.
  • Bojke L, Claxton K, Bravo Vergel Y, Sculpher M, Palmer S, Abrams K. Eliciting distributions to populate decision analytic models. Value in Health 2010;13(5):557-64. Download from Wiley interscience
  • Campbell JD, Spackman DE. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy 2010;65(9):1141-48.
  • Carr-Hill R. The poor may always be with us; but we don’t know how many there are or where they are. Journal of Health Services Research and Policy 2010;15:121-130.
  • Carr-Hill R, Roberts F, Currie E. Approaches to costing adult literacy programmes, especially in Africa. International Journal of Educational Development 2010;30:428-37.
  • Chambers D, Worthy G, Myers L, Weatherly H, Elliott R, Hawkins N, Sculpher M, Eastwood A. Glycopeptide versus non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surg Infect 2010;11(5):455-62.
  • Chuang LH, Kind P. The Effect of Health State Selection on the Valuation of EQ-5D. Medical Decision Making 2010;31(1):186-194.
  • Cookson R, Culyer AJ.  Measuring overall population health - the use and abuse of QALYs, in Killoran A, Kelly M (eds). Evidence based public health: effectiveness and efficiency, Oxford: Oxford University Press, 2010, 148-168.
  • Cookson R, Dusheiko M, Hardman G, Martin S. Competition and inequality: evidence from the English national health service 1991-2001. Journal of Public Administration Research and Theory 2010;20:181-205.
  • Cox H, Tilbrook H, Aplin J, Chuang LH, Hewitt C, Jayakody S, Semlyen A, Soares M, Torgerson DJ, Trewhela A, Watt I, Worthy G. A pragmatic multi-centred randomised controlled trial of yoga for chronic low back pain: trial protocol. Complementary Therapies for Clinical Practice 2010;16(2):76-80. Download from Elsevier
  • Culyer AJ. The dictionary of health economics. 2nd Edition, Cheltenham: Edward Elgar, 2010.
  • Culyer AJ. Perspective and desire in comparative effectiveness research - the relative unimportance of mere preferences, the central importance of context. Pharmacoeconomics 2010;28:889-97.
  • Elliot RA, Weatherly HLA, Hawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? European Journal of Health Economics 2010;11(1):57-66. Download from springerlink
  • Fabbri D, Robone S. The geography of hospital admission in a National Health Service with patient choice: evidence from Italy. Health Economics 2010;19(9):1029-47.
  • Goddard M, Gravelle H, Hole A, Marini G. Where did all the GPs go? Increasing supply and geographical equity in England and Scotland. Journal of Health Services Research and Policy. 2010;15(1):28-35. Download from sage.
  • Gohel MS, Epstein D, Davies AH. Cost-effectiveness of traditional and endovenous treatments for varicose veins. Br J Surg 2010;97(12):1815-23. Download from pubmed
  • Gomes M, Soares MO, Dumville J, Lewis SC, Torgerson D, Bodenham A.R, Gough MJ, Warlow CP and the GALA collaborative group. Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial). British Journal of Surgery 2010;97(8):1218-1225. Download from BJS
  • Gravelle H, Sutton M, Ma A. Doctor behaviour under a pay for performance contract: treating, cheating and case finding? Economic Journal 2010;120:F129-F56.
  • Griffin S, Claxton K, Welton N. Exploring the research decision space: the expected value of information for sequential research designs. Medical Decision Making 2010;30:155-62. Download from Sage journals
  • Gutacker N, Neumann A, Santosa F, Moysidis T, Kroeger K. Amputations in PAD patients - data from the German federal statistical office. Vascular Medicine 2010;15:9-14.
  • Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. Breaking down the wall of silence around children affected by AIDS in Thailand to support their psychosocial health. Aids Care 2010;22:308-13.
  • Kristensen T, Laudicella M, Ejersted C, Street A. Cost variation in diabetes care delivered in English hospitals. Diabetic Medicine 2010;27(8):949-57.
  • Jones AM, Rice N, Roberts J. Early retirement among men in Britain and Germany: how important is health? The Geneva papers on risk and insurance: issues and practice (Special issue on health and ageing) 2010;35:644-67.
  • Jones AM, Rice N, Rosa-Dias P. Quality of schooling and inequality of opportunity in health. Health, Econometrics and Data Group (HEDG), University of York 2010;10/22.
  • Jones AM, Rice N, Rosa-Dias P. Long-term effects of cognitive skills, social adjustment and schooling on health and lifestyle: Evidence from a reform of selective schooling. Health Economics and Data Group (HEDG), University of York Working Paper 2010;10/11.
  • Jones AM, Rice N, Robone S, Rosa-Dias P. Inequality and polarisation in health systems' responsiveness: a cross-country analysis. Health Economics and Data Group (HEDG), University of York working Paper 2010;10/27.
  • Laudicella M, Siciliani L, Cookson R. Waiting times and socioeconomic status: evidence from England. Health Econometrics and Data Group(HEDG), University of York 2010;10/05.
  • Laudicella M, Olsen KR, Street A. Examining cost variation across hospital departments - a two-stage multilevel approach using patient level data. Social Science and Medicine 2010;71(10):1872-1881.
  • Luce B, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, Sullivan SD. (The International Working Group for HTA Advancement ) EBM, HTA and CER: clearing the confusion. The Millbank Quarterly 2010;88:256-76.
  • Manca A, Eldabe S, Buchser E, Kumar K, Taylor RS. Relationship between health related quality of life, pain and functional disability in neuropathic pain patients with failed back surgery syndrome. Value in Health. 2010;13(1):95-102.
  • Manca A, Sculpher M, Goeree R. The analysis of multinational cost effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics 2010;28:1079-96.
  • Marks L, Cave S, Hunter DJ, Mason JM, Peckham S, Wallace A, Mason A, Weatherly H, Melvin K. Public health governance and primary care delivery: a triangulated study. final report; NIHR Service Delivery and Organisation programme 2010. 
  • Mason A, Drummond M, Ramsey S, Campbell J, Raisch D. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric? Journal of Clinical Oncology 2010;28(20):3234-38.
  • Mason A, Street A, Verzulli R. Private sector treatment centres are treating less complex patients than the NHS. Journal of the Royal Society of Medicine 2010;103:322-31.
  • Maund E, McKenna C, Sarowar M. Dronedarone for the treatment of atrial fibrillation and atrial flutter. Health Technology Assessment 2010;14:Suppl.2. Download from pubmed
  • McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, Cooper N, Abrams K. Continuing the multiple sclerosis risk sharing scheme is unjustified. British Medical Journal 2010;340(C1786) Download from BMJ
  • McKenna C , Burch J, Suekarran S. Aldosterone antagonists for post-myocardial infarction heart failure. Health Technology Assessment 2010;14(24):161.
  • McKenna C, Chalabi Z, Epstein D, Claxton K. Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions. Journal of Health Economics 2010;29(1):170–181. Download from Science Direct
  • McKenna C, Hawkins N, Claxton K, McDaid C, Suekarran S, Light K, Chester M, Cleland J, Woolacott N, Sculpher M. Cost-effectiveness of Enhanced External Counterpulsation (EECP) for the treatment of stable angina in the UK. International Journal of Technology Assessment in Health Care 2010;26(2):175-82. Download from Pubmed
  • McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer disease severity. Alzheimer's & Dementia 2010;6(6):482-03.
  • Neumann PJ, Drummond MF, Jonsson B, Luce BR, Schwartz JS, Siebert U, Sullivan S. Are key principles for improved health technology assessment supported and used by health technology assessment organizations? International Journal of Technology Assessment in Health Care 2010;26:71-78.
  • Norman G, Soares M, Peura P, Rice S, Suh D, Wright K, Sculpher M, Eastwood A. Capecitabin for advanced gastric cancer. Health Technology Assessment 2010;14(s2). Download from  Pubmed
  • Paton F, Paulden M, Saramago P, Manca A, Misso K, Palmer S, Eastwood A. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. Health Technology Assessment, 2010;14(S1):55-62.
  • Pattenden J, Mason A. Better Together: An end of life initiative for patients with heart failure and their families. M123S: Executive summary. British Heart Foundation, London. June 2010. Download from BHF
  • Pattenden J, Mason A. Better Together: An end of life initiative for patients with heart failure and their families. M123R: Final Report. British Heart Foundation, London. June 2010. Download from BHF
  • Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M. Alitretinoin for the treatment of severe chronic hand eczema. Health Technology Assessment 2010;14(s1):39-46. Download from NIHR
  • Pichon-Riviere A, Augustovski F, Rubinstein A, Marti SG, Sullivan SD, Drummond M. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? International Journal of Technology Assessment in Health Care2010;26:421-27.
  • Pridmore P, Carr-Hill R. Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed? Public Health Nutrition 2010;19:1-6.
  • RESPECT Trial Team. Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. British Journal of General Practice. 2010;60:21-27.
  • Rice N, Robone S, Smith PC. International comparison of public sector performance: the use of anchoring vignettes to adjust self-reported data. Evaluation 2010;16:81-101.
  • Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Wollacott N, Sculpher M. Alitretinoin for severe chronic hand eczema: A NICE single technology appraisal. Pharmacoeconomics 2010;28(5):351-62. Download from Pubmed
  • Scheller-Kreinsen D, Geissler EA, Street A, Busse R. Leistungsbewertung von deutschen krankenhäusern - stärken, schwächen und vergleichbarkeit der bekannten methoden. Gesundh ökon Qual manag 2010;15:1-11.
  • Schut FT, Van den Berg B. Sustainability of comprehensive universal long-term care insurance in the Netherlands. Social Policy and Administration 2010;44:411-35.
  • Sculpher M, Claxton K. Sins of omission and obfuscation: IQWiG’s guidelines on economic evaluation methods. Health Economics 2010;19(10):1132-36.
  • Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, Drummond MF. Evidence synthesis, economics and public policy. Research Synthesis Methods 2010;1:126-135.
  • Spilsbury K, Adamson J, Atkin K, Bloor K, Carr-Hill R, McCaughan D, McKenna H, Wakefield A. Challenges and opportunities associated with the introduction and development of assistant practitioners supporting the work of ward-based registered nurses in acute NHS trusts in England. Journal of Health Services Research and Policy 2010;Supplement.
  • Spilsbury K, Bloor K, Bartlett C, Bonsanquet K, Carr-Hill R. Assistant practitioners: identity, responsibilities and development. British Journal of Healthcare Assistants 2010;4:599-602.
  • Street A. Letter in response to articles on Choice and Competition. Health Economics, Policy and Law 2010;5(2):247.
  • Street A, Scheller-Kreinsen D, Geissler A, Busse R. Determinants of hospital costs and performance variation: methods, models and variables for the EuroDRG project. Working Papers in Health Policy and Management 2010;Vol.3 May:Berlin: Universitätsverlag der TU Berlin. Download from eurodrg
  • The United Kingdom EVAR trial investigators. Endovascular versus open repair of abdominal aortic aneurysm. New England Journal of Medicine 2010;362:1863-71. Download from NEJM
  • The United Kingdom EVAR trial investigators. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. New England Journal of Medicine 2010;362:1872-80. Download from NEJM
  • Vitikainen K, Linna M, Street A. Substituting inpatient for outpatient care: what is the impact on hospital costs and efficiency? European Journal of Health Economics 2010;11(4):395-404. Download from springerlink
  • Wailoo AJ, Goodacre S, Sampson F, Hernandez M, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder MA, Gray H. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty Project. Heart 2010;96:668-72.
  • Walker S, Mason A, Claxton K, Cookson R, Fenwick E, Fleetcroft R, Sculpher M. Value for money and the quality and outcomes framework in primary care in the NHS. British Journal of General Practice 2010;60(574):352-57. Download from BJGP
  • Walker D, Teerawattanonon Y, Anderson R, Richardson G. Generalisability, transferability, complexity and relevance. In: Shemilt I, Mugford M, Vale L, Marsh K, Donaldson C, editors. Evidence-based decisions and economics: health care, social welfare, education and criminal justice, 2nd Edition: Wiley-Blackwell; 2010.
  • Wearden AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Riste L, Richardson G, Lovell K, Dunn G. A randomised controlled trial of a nurse-led home-based self-help treatment for patients in primary care with chronic fatigue syndrome - the FINE trail. BMJ 2010;340:C1777.
  • Weatherly H, Mason A, Goddard M, Wright K. Financial integration across health & social care: evidence review. Scottish Government Social Research; 2010.

2009

  • Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Garcia Marti S. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics 2009;27(11):919-29.
  • Austin PC, Manca A, Zwarenstein M, Juurlink DN, Stanbrook MB. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. Journal of Clinical Epidemiology, 2009;63(2):142-153.
  • Barbieri M, Hawkins N, Sculpher MJ. Who does the numbers? The role of third-party technology assessments to inform health systems' decision-making about the funding of health technologies. Value in Health. 2009;12:193-201.
  • Bojke L, Claxton K, Sculpher M, Palmer S . Characterizing structural uncertainty in decision-analytic models: a review and application of methods. Value in Health. 2009;12:739-49.
  • Bowyer S, Caraher M, Elbert K, Carr-Hill R. Shopping for food: lessons from a London borough. British Food Journal 2009;11:453-73.
  • Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(9):537-45.
  • Burch J, Epstein D, Baba-Akbari Sari A, Weatherly H, Jayne D, Fox D et al. Stapled haemorrhoidopexy for the treatment of haemorrhoids: a systematic review. Colorectal Disease. 2009;11:233-44.
  • Burch J, McKenna C, Palmer S, Norman G, Glanville J, Sculpher M, Woolacott N. Rimonabant for the treatment of overwieght and obese people. Health Technology Assessment 2009:13(Suppl3);3. Download from HTA
  • Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton N, Ades AE, Sutton A, Cooper N, Elliot A, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess. 2009;13(58):1-290. Download from HTA
  • Carr-Hill R . Data monitoring and evaluation, annex F. mid-term evaluation of the EFA fast track initiative 2009.
  • Carr-Hill R , Mason A, Street A. NICE Guidance on Cost Effectiveness of Community Engagement to Improve Health; 2009.
  • Castelli A, Jacobs R, Goddard M, Smith P . Geographical variation in quality of life: The role of public service organisations. Policy Briefing, Centre for Health Economics, University of York; 2009.
  • Castelli A, Jacobs R, Goddard M. Exploring the impact of public services on quality of life indicators: Public Services Programme: Quality, Performance & Delivery, Discussion Paper DP0902 2009.
  • Castelli A, Laudicella M, Street A, Ward P. Getting out what we put in (PDF , 224kb)‎ how productive is the NHS in England? Paper presented at the Health Economic Study Group Meeting. Sheffield 22-24 July 2009.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. The challenges of developing cost-effective public health guidance: a NICE perspective. In: Dawson S, Morris ZS, editors. Future public health: burdens, challenges and opportunities. Basingstoke: Palgrave Macmillan; 2009. p.276-91.
  • Chambers D, Epstein D, Walker S, Fayter D, Paton F, Wright K, et al. Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model. Health Technology Assessment 2009;13(48).
  • Chuang LH, Zarate V, Kind P. Estimating domestic values for EQ-5D health states using survey data from external sources. Medical Care 2009;47(2):168-75.
  • Conti S, Claxton K . Dimensions of design space: a decision theoretic approach to optimal research portfolio design. Medical Decision Making 2009;29:643-60. Download from Sage Journals online
  • Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith S, Nunn AJ, Manca A, Sculpher M et al. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin-treated diabetes (MITRE Study). Diabetic Medicine 2009;26(5):540-7. Download from Wiley InterScience
  • Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Economics Policy and Law. 2009;4(2):231-45.
  • Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Reply to Richardson and Shiell. Health Economics Policy and Law.2009;4(2):261-263.
  • Cookson R, Laudicella M. Do the poor still cost more? The relationship between small area income deprivation and length of stay for elective hip replacement in the English NHS from 2001/2 to 2006/7. Health Economics and Data Group (HEDG), University of York Working Paper 09/07 2009.
  • Culyer AJ. Health, distribution and fairness - sorting out the theory and matching it to future policy practice (notes for the Select Committee on Health) House of Commons Select Committee on Health, 3rd Report:Health Inequalities;2009.
  • Culyer AJ. Deliberative processes in decisions about health care technologies: combining different types of evidence, values, algorithms and people. London: Office of Health Economics; 2009.
  • Culyer AJ. How nice is NICE? A conversation with Anthony Culyer, Health Care Cost Monitor, 2009 Hastings Centre Blog.
  • Dixon J, Asaria P, Georghiou T, Billings J, Gravelle H, Martin S, Rice N, Smith P, Wennberg D, DeLorenzo M, Siegal M, Russell R, Filipova N. Developing a person based resource allocation formula for general practices in England. Report to the Department of Health; October 2009.
  • Dobrow MJ, Chafe R, Burchett HED, Culyer AJ, Lemieux-Charles L. Designing deliberative methods for combining heterogeneous evidence: A systematic review and qualitative scan. A report to the Canadian Health Services Research Foundation. Ottawa; 2009.
  • Drummond M , Barbieri M, Cook J, Glick H, Lis J, Malik F, Reed S, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR Good Practices Task Force report. Value in Health. 2009;12:409-18.
  • Drummond M, Brixner D, Gold M, Kind P, McGuire A, Nord E. Consensus Development Group (2009) Toward a consensus on the QALY. Value in Health 2009;12(Suppl1):S31-35.
  • Dumville JC, Soares M. The economics of clinical decision making. In: Essential Decision Making and Clinical Judgement for Nurses. London: Churchill Livingstone; 2009.
  • Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares M, Torgerson DJ. VenUS II team. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. British Medical Journal 2009;Mar 19:338:b773. Download from BMJ
  • Dumville JC, Worthy G, Soares M, Bland JM, Cullum N, Dowson C, Iglesias C, McCaughan D, Mitchell JL, Nelson EA, Torgerson DJ. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers: Health Technology Assessment 2009 Nov;13(55):1-182, i-iv. Download from HTA
  • Elliot RA, Weatherly HLA, Hawkins NS, Cranny G, Chambers D, Myers L, Eastwood A, Sculpher MJ. An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? European Journal of Health Economics 2009;11(1):57-66. Download from springerlink
  • Epstein D. Is EVAR worth the price difference? In: Greenhalgh R, editor. Vascular and Endovascular Controversies Update 31. London:Biba Medical;2009.
  • Epstein D. Opportunity Cost. In: Encyclopedia of Medical Decision Making. Sage Publications; 2009.
  • Epstein D, Bojke L, Sculpher M & the REFLUX trial group. The cost-effectiveness of laparoscopic fundoplication versus medical management for gastro oesophageal reflux disease. British Medical Journal 2009;338:b2576.
  • Epstein D, Jimenez Rubio D, Smith PC, Suhrcke M. Social determinants of health: an economic perspective. Health Economics 2009;18:495-502.
  • Gauthier A, Manca A, Anton S. Bayesian modelling of healthcare resource use in multinational randomised clinical trials. Pharmacoeconomics 2009;27(12):1017-1029.
  • Goddard M, Jacobs R. Using composite indicators to measure performance in health care. In: Smith PC, Mossialos E, Leatherman S, Papanicolas I, editors. Performance Measurement for Health System Improvement: experiences, challenges and prospects. Cambridge:Cambridge University Press;2009.Chapter 3.4. 
  • Goddard M, Mason A. Mental health learning points (PDF , 63kb). Healthcare Finance 2009 (November);pp39,41.
  • Gravelle H, Sutton M. Income, relative income, and self-reported health in Britain 1979-2000. Health Economics 2009;18(2):125-45.
  • Gravelle H, Sivey P. Imperfect quality information in a quality-competitive hospital market. Department of Economics and Related Studies (DERS), University of York Discussion Paper 2009;09/09.
  • Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, Dickinson C, Younger JF, Ridgeway JP, Sculpher M, Ball SG, Plain S. Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. Trials 2009;10:p62 (doi:10.1186/745-6215-10-62).
  • Griffin S , Dunn G, Palmer S, Macfarlane S, Brent S, Dyker A, et al. The use of paclitaxel in the management of early stage breast cancer. Health Technology Assessment 2009;13(s1):15-22.
  • Griffin S, Rice N, Sculpher M. Economic evaluation of public health interventions. In: Killoran A, Kelly M, editors. Evidence-based public health: effectiveness and efficiency. Oxford:Oxford University Press;2009.
  • Griffin S, Walker S, Sculpher M, et al. Cetuximab plus radiotherapy for the treatment of locally advance squamous cell carcinmoa of the head and neck. Health Technology Assessment 2009;13(s1):49-54. Download from HTA
  • Hann M, Goudie R, Sutton M, Gravelle H, Sibbald B. The Fifth National GP Worklife Survey. Final Report to Department of Health; June 2009.
  • Hewitt C, Gilbody S, Brealey S, Paulden M, Palmer S, Mann R, Green J, Morrell J, Barkham M, Light K, Richards D. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technology Assessment 2009;13(36):1-145,47-230. Download from HTA
  • Hoomans T, Fenwick E, Palmer S, Claxton K. Value of information and value of implementation: application of a framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer. Value in Health 2009;12:315-24. Download from wiley InterScience
  • Hvenegaard A, Street A, Sørensen TH, Gyrd-Hansen D. Comparing hospital costs: what is gained by accounting for more than a case-mix index? Social Science & Medicine 2009;69:640-47.
  • Iglesias C, Manca A, Torgerson D. The health related quality of life and cost implications of falls in elderly women. Osteoporosis International 2009;Jun20(6):869-78.
  • Jacobs R. Which services improve our quality of life? Britain in 2010 magazine 2009:39.
  • Jacobs R, Castelli A, Goddard M, Smith PC. Impact of public services on quality of life indicators? LariaNews, LARIA Newsletter, Local Authorities Research Intelligence Association 2009.
  • Jacobs R, Chaloupka F, Tauras J, Water H. Taxation and the economics of tobacco control. In: Samet JM, Yoon SY, editors. Women and the Tobacco Epidemic: Challenges for the 21st century. Geneva: WHO; 2009.
  • Jacobs R, Street A. Final report: Efficiency analysis of PFI schemes: Report for the National Audit Office, November, pp34;2009.
  • Jacobs R, Street A. The relative efficiency of services delivered through hospital PFI contracts: feasibility study, Report for the National Audit Office York, Centre for Health Economics:14pp;2009.
  • Laudicella M, Cookson R, Jones AM, Rice N. Health care deprivation profiles in the measurement of inequality and inequity: an application to GP fundholding in the English NHS. Journal of Health Economics 2009;28(6):1048-61. Download from Sciencedirect
  • Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, Kind P, Kweon SS, Kim YT. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value in Health 2009;12(8):1187-93.
  • Manca A. Economic evaluation of medical devices and drugs - same or different? (Editorial). Value in Health 2009;12(4):401.
  • Manca A. Task force report on good research practices on economic data transferability in HTA (Editorial). Value in Health 2009;12(4):407.
  • Mannion R, Harrison S, Jacobs R, Konteh F, Walsh K, Davies HTO. From cultural cohesion to rules and competition: the trajectory of senior management culture in English NHS hospitals, 2001-2008. Journal of the Royal Society of Medicine 2009;102:332-36.
  • Mannion R, Street A. Managing activity and expenditure in the new NHS market: evidence from South Yorkshire. Public Money and Management 2009;29(1):27-34. Download from Taylor and Francis
  • Marini G, Miraldo M. Economies of scale and scope in the English hospital sector. Imperial College Business School Discussion Papers, 2009/05.
  • Martin S, Dusheiko M, Gravelle H, Rice N. Estimating needs for programme budget areas. Report to the Department of Health; December 2009.
  • McDaid C, Duree KH, Griffin SC, Weatherly HLA, Stradling JR, Davies RJO, Sculpher MJ, Westwood ME. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Medicine Reviews 2009;13(6):427-36. Details from Sleep Medicine Reviews 
  • McDaid C, Griffin S, Weatherly H, Duree KH, Burgt van der M, Hout van S, Akers J, Davies RJO, Sculpher M, Westwood M. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technology Assessment. 2009;13(4)pp1-142.
  • McKenna C, Bojke L, Manca A, et al. Shoulder acute pain in primary healthcare: Is retraining GP's effective (SAPPHIRE) randomised trial - cost effectiveness analysis. Rheumatology 2009;48:558-563.
  • McKenna C, McDaid C, Suekarran S, Hawkins N, Claxton K, Light K, Chester M, Cleland J, Woolacott N, Sculpher M. Enhanced external counterpulsation (EECP) for the treatment of stable angina and heart failure: A systematic review and economic analysis. Health Technology Assessment 2009;13(24):1-112. Download from HTA
  • McKenna C, Palmer S , Rodgers M, et al. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the UK. Heart 2009;95:542-9. Download from BMJ
  • Mason A, Street A, Miraldo M, Siciliani L. Should prospective payments be differentiated for public and private healthcare providers? Health Economics, Policy and Law. 2009;4(4):383-403. Download from Cambridge journals.
  • Newman SP, Cooke D, Casbard A, Walker S, Meredith S, Nunn A, Steed L, Manca A, Sculpher M, et al. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technology Assessment. 2009;May;13(28):iii-iv, ix-xi,1-194.
  • Pridmore P, Carr-Hill R. Addressing the underlying and basic causes of child undernutrition in developing countries: what works and why?” for DANIDA;2009.
  • Richardson G, Bloor K, Williams J, Russell I, Durai D, Cheung W-Y, et al. Cost-effectiveness of nurse-delivered endoscopy: findings from a randomised multi-institution nurse endoscopy trial (MINuET) BMJ 2009;338:b270.
  • Richardson G, Bojke C, Kennedy A, Reeves D, Bower P, Lee V et al. What outcomes are important to patients with long term conditions? A discrete choice experiment. Value in Health 2009;12(2):331-9.
  • Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis. Health Technology Assessment. 2009;13(31):1-77. Download from HTA
  • Santana P, Santos R, Nogueira H. The link between local environment and obesity: a multilevel analysis in the Lisbon Metropolitan Area, Portugal. Social Science & Medicine 2009;68(4):601–609.
  • Sculpher MJ, Lozano-Ortaga G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, et al. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. American Heart Journal 2009;157:845-52.
  • Siciliani L. Paying for performance and motivation crowding out. Economics Letters 2009;103:68-71.
  • Siciliani L, Gravelle H. Third degree waiting time discrimination: optimal allocation of a public sector healthcare treatment under rationing by waiting. Health Economics. 2009;18:977-86.
  • Siciliani L, Stanciole A, Jacobs R. Do waiting times reduce hospitals' costs? Journal of Health Economics 2009;28(4):771-80.
  • Siciliani L, Verzulli R. Waiting times and socioeconomic status among elderly Europeans: evidence from SHARE. Health Economics 2009;18(11):1295-306.
  • Soares M, Iglesias CP , Bland JM, Cullum N, Dumville JC, Nelson EA, Torgerson DJ, Worthy G. VenUS II team. Cost effectiveness analysis of larval therapy for leg ulcers British Medical Journal 2009 Mar;19:338:b825 doi:10.1136/bmj.b825. Download from BMJ
  • Smith PC, Goddard M. The English National Health Service: an economic health check. Report for Organisation for Economic Co-operation and Development ECO/WKP58 July; 2009.
  • Spilsbury K, Stuttard L, Adamson J, Atkin K, Borglin G, McCaughan D, McKenna H, Wakefield A, Carr-Hill R. Mapping the introduction of assistant practitioner roles in acute NHS (hospital) trusts in England. Journal of Nursing Management 2009;17:615-26.
  • Street A, Hakkinen U. Health system productivity and efficiency. In: Smith PC, Mossialos E, Leatherman S, Papanicolas IN, editors. Performance measurement for health system improvement: experiences, challenges and prospects. World Health Organisation; 2009.
  • Street A, Laudicella M. Identifying inefficiency (PDF , 415kb): Why do costs differ from one hospital to another? Policy Briefing, Centre for Health Economics, University of York; 2009.
  • Taylor RS, Iglesias CP. Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? Value in Health 2009;Jun 12(4):404-6.
  • Vallejo-Torres L, Morris S, Carr-Hill R, Dixon P, Law M, Rice N, Sutton M. Can regional resource shares be based only on prevalence data? an empirical investigation of the proportionality assumption. Social Science Medicine 2009;69:1634-42.
  • Vitikainen K, Street A, Linna M. Estimation of hospital efficiency - do different definitions and casemix measures for hospital output affect the results? Health Policy 2009;89:149-59.
  • Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane S, White S, Thomas S. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia. Health Technology Assessment 2009;13(sl):35-40. Download from HTA
  • Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Sculpher M, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy 2009;93:85-92. Download from Elsevier 
  • Weatherly HLA, Griffin S, McDaid C, Duree KH, Davies RJO, Stradling JR, Sculpher MJ et al. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. International Journal of Technology Assessment in Health Care. 2009;25(01):26-34.
  • Williams J, Russell I, Durai D, Cheung W-Y, Farrin A, Bloor K, Coulton S, Richardson G. Effectiveness of nurse-delivered endoscopy: findings from a randomised multi-institution nurse endoscopy trial (MINuET) British Medical Journal. 2009;338:b231.

2008/2007

2008

  • Al-Ruzzeh S, Epstein D, George S, Bustami M, Wray J, Ilsley C, Sculpher M, Amrani M. Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial. Artificial Organs 2008;32(11):891-7. Download from Wiley InterScience
  • Bansback N, Sun H, Guh D, Li X, Nosyk B, Griffin S et al. The impact of using a recall period on the measurement of health utilities for acute events. Health Economics 2008;17(12):1413-1419.
  • Bojke L, Claxton K, Sculpher M, Palmer S, Philips Z. The cost-effectiveness and value for information associated with repeat screening for age related macular degeneration. Medical Decision Making 2008;28:33-43. Download from Sage Journals Online
  • Bravo Vergel Y, Sculpher M. Quality-adjusted life years. Practical Neurology 2008;8:175-82. Download from BMJ
  • Brouwer WBF, Culyer AJ, Job N, van Exel A, Rutten FFH. Welfarism vs. extra-welfarism. Journal of Health Economics 2008;27:325-38.
  • Burch J, Epstein D, Baba-Akbari A, Weatherly H, Fox D, Golder S, Jayne D, Drummond M, Woolacott N. Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technology Assessment 2008;12(8). Download from HTA
  • Chalabi Z, Epstein D, McKenna C, Claxton K. Uncertainty and value of information when allocating resources within and between healthcare programmes. European Journal of Operational Research 2008;191(2):530-9. Download from Science Direct
  • Chalkidou K, Culyer AJ, Littlejohns P, Doyle P, Hoy A. Imbalances in funding for clinical and public health research in the UK: can NICE research recommendations make a difference? Evidence and Policy 2008;4:355-69.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. Cost-effective public health guidance: asking questions from the decision-maker's viewpoint. Health Economics 2008;17:441-8.
  • Chalkidou K, Walley T, Culyer AJ, Littlejohns P, Hoy A. Evidence-informed evidence making. Journal of Health Services Research and Policy 2008;13:167-73.
  • Chauhan D, Mason A. Factors affecting the uptake of new medicines in secondary care - a literature review. Journal of Clinical Pharmacy and Therapeutics 2008;33(4):339-48.
  • Cheraghi-Sohi S, Hole A, Mead N, McDonald R, Whalley D, Bower P, et al. What do patients want from a primary care consultation: A stated preference discrete choice experiment to identify patient priorities. Annals of Family Medicine 2008;6(107-115).
  • Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008;9:781-98.
  • Claxton K, Briggs A, Buxton M, Culyer A, McCabe C, Walker S, Sculpher M. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008;336:251-4. Download from BMJ
  • Claxton K, Culyer A. Not a NICE fallacy: A reply to Dr Quigley. Journal of Medical Ethics 2008;34:598-601. 
  • Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.  A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.  Health Technology Assessment 2008;12:1-168.
  • Culyer AJ, Amick B, LaPorte A. What is a little more health and safety worth? In:Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford:Oxford University Press 2008:15-35.
  • Culyer AJ, Tompa E. Equity. In:Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:215-31.
  • Culyer A, Sculpher M. Lessons from health technology assessment. In:Tompa E, Culyer A, Dolinschi R, eds. Economic Evaluation of Interventions for Occupational Health and Safety. Oxford:Oxford University Press 2008.
  • Doran T, Fullwood C, Gravelle H, Reeves D, Roland M. Should physicians be allowed to exclude individual patients from pay for performance targets? Analysis of exception reporting in the UK pay for performance scheme. New England Journal of Medicine. 2008;359;274-284.
  • Drummond M, Iglesias C, Cooper NJ. Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellance in the United Kingdom: A game of two halves? International Journal of Technology Assessment in Health Care 2008;24:146-50. Download from Cambridge Journals
  • Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ. Key principles for the improved conduct of health technology assessments for resource allocation decisions. International Journal of Technology Assessment in Health Care 2008;24(3):244-58.
  • Drummond M, Weatherly H, Ferguson B. Economic evaluation of health interventions: a broader perspective is needed that include potential cost and benefits for all stakeholders. British Medical Journal 2008;337:a1204.
  • Dusheiko M, Goddard M, Gravelle H, Jacobs R. Explaining trends in concentration of health care commissioning in the English NHS. Health Economics 2008;17(8):907-26. Download from Wiley Inter Science
  • Epstein DM, Garcia Mochon L. The accuracy of telemedicine compared with conventional methods in the diagnosis of malignant melanoma of the skin. Revista Espanola de Economia de la Salud 2008;7:193-6.
  • Epstein D, Sculpher M, Clayton T, Henderson R, Pocock SJ, Buxton M, et al. Costs of an early intervention versus a conservative strategy in acute coronary syndrome. International Journal of Cardiology 2008;127(2):240-6. Download from ScienceDirect
  • Epstein D, Sculpher M, Manca A, Michaels J, Thompson SG, Brown LC, et al. Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. British Journal of Surgery 2008;95:183-90.
  • Epstein D, Mason A, Manca A. The hospital costs of care for stroke in nine European countries. Health Economics 2008;17 (S1):S21-S31. Download from Wiley inter science
  • Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development. Medical Decision Making 2008;28:21-32. Download from Sage Journals Online
  • Golder S, Mason A, Spilsbury K. Systematic searches for the effectiveness of respite care. Journal of the Medical Library Association 2008;96(2):147-52.
  • Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M , et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technology Assessment 2008;12(31):1-204.
  • Gravelle H, Morris S, Sutton M. Are family physicians good for your health? Endogenous supply and health. Health Services Research 2008;43(4):1128-1144.
  • Gravelle H, Siciliani L. Optimal quality, waits and charges in health insurance. Journal of Health Economics 2008;27(3):663-74.
  • Gravelle H, Siciliani L. Is waiting-time prioritisation welfare improving? Health Economics 2008;17:167-85.
  • Gravelle H, Siciliani L. Ramsey waits: allocating public health service resources when there is rationing by waiting. Journal of Health Economics 2008;27(5):1143-54.
  • Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. Journal of Health Services Research and Policy 2008;13:23-30. Download from RSM Press
  • Griffin S, Weatherly H, Richardson G, Drummond M. Methodological issues in undertaking independant cost-effectiveness analysis for NICE: the case of therapies for ADHD. The European Journal of Health Economics 2008;9(2):137-45.
  • Henriksson M, Epstein D, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, et al. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart 2008;94:717-23. Download from BMJ
  • Hicks L, Gibbs I, Weatherly H, Byford S. Management, leadership and resources in children's homes: what influences outcomes in residential child-care settings? British Journal of Social Work 2008;39(5):828-845. Download from Oxford Journals
  • Hurley J, Pasic D, Lavis J, Culyer AJ, Mustard C, Gnam W. Parallel payers and preferred access: how Canada's workers' compensation boards expedite care for injured and ill workers. HealthcarePapers 2008;8:6-14.
  • Hurley J, Culyer AJ, Gnam W, Lavis J, Mustard C, Pasic D. Response to commentaries. HealthcarePapers 2008;8:52-4.
  • Hurley J, Pasic D, Lavis J, Mustard C, Culyer AJ, Gnam W. Parallel lines do intersect: interactions between the workers' compensation and provincial publicly financed health care systems in Canada. Health Care Policy 2008;3:100-12.
  • Manca A, Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, Taylor RJ, Goeree R, Sculpher MJ. Quality of life, resource consumption and costs of spinal cord simulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain 2008;12:1047-58.
  • Manesh AO, Sheldon TA, Pickett KE, Carr-Hill R. Accuracy of child morbidity data in demographic and health surveys. International Journal of Epidemiology 2008;37:194-200. 
  • Mannion R, Marini G, Street A. Implementing payment by results in the English NHS: changing incentives and the role of information. Journal of Health Organization and Management 2008;22(1):79-88.
  • Marini G, Miraldo M, Jacobs R, Goddard M. Giving greater financial independence to hospitals - does it make a difference? the case of English NHS Trusts. Health Economics 2008;17(6):751-75.
  • Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data. Journal of Health Economics 2008;27(4):826-42.
  • Mason A. New medicines in primary care: a review of influences on general practitioner prescribing. Journal of Clinical Pharmacy and Therapeutics 2008;33:1-10.
  • Mason A, Carr-Hill R, Myers L, Street A. Establishing the economics of engaging communities in health promotion: what is desirable, what is feasible? Critical Public Health 2008;18(3):285-97.
  • Mason AR, Drummond M. NHS Reimbursement of new cancer drugs: is NICE getting nastier? (abstract from the ISPOR thirteenth annual international meeting May 3-7 2008). Value in Health 2008;11(3):A11.
  • Mason A, Walker S, Claxton K, Cookson R, Fenwick E, Sculpher M. The GMS quality and outcomes framework (PDF , 238kb) : Are the quality and outcomes framework (QOF) indicators a cost-effective use of NHS resources? In: Quality and Outcomes Framework. Joint executive summary: Reports to the Department of Health from the University of East Anglia and the University of York. 
  • McCabe C, Claxton K, O'Hagan A. Why licensing authorities need to consider the net value of new drugs - addressing the tension between licensing and reimbursement. International Journal of Technology Assessment in Health Care 2008;24:140-5. Download from Cambridge Journals
  • McCabe C, Culyer A, Claxton K. The NICE cost-effectiveness threshold: what it is and what it means. Pharmacoeconomics 2008; 9:733-44.
  • Morris S, Gravelle H. GP supply and obesity. Journal of Health Economics 2008;27(5):1357-67.
  • Olry de Labry Lima A, Sordo del Castillo L, Garcia Mochon L, Epstein D, Bermudez C, Villegas R. Evaluacion economica de la prueba genetica de la poliposis adenomatosa familiar. Rev Esp Enfirm Dig 2008;100(8):470-5.
  • Olsen KR, Street A. The analysis of efficiency among a small number of organisations:how inferences can be improved by exploiting patient-level data. Health Economics 2008;17(6):671-81. Download from Wiley
  • Phillips Z, Claxton K, Palmer S. The half-life of truth? what is the appropriate time horizons for research decisions? Medical Decision Making 2008;28:287-99. Download from Sage Journals Online
  • Reeves D, Kennedy A, Fullwood C, Bower P, Gardner C, Gately C, Lee V, Richardson G, Rogers A. Predicting who will benefit from an expert patients programme self-management course. British Journal of General Practice 2008;58(548):198-203.
  • Richardson G, Kennedy A, Reeves D, Bower P, Lee V, Middleton E, et al. Cost-effectiveness of the expert patient programme (EPP) for patients with chronic conditions. Journal of Epidemiology and Community Health 2008;62:361-367.
  • Rodgers M, McKenna C, Palmer S, et al. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technology Assessment 2008;12(34). Download from HTA
  • Rogers A, Kennedy A, Reeves D, Bower P, Lee V, Gardner C, Gately C, Richardson G. The UK expert patients programme: results and implications from a national evaluation. Medical Journal of Australia 2008;Nov17:189(10 Suppl):S21-4.
  • Ryan M, Griffin S, Chitah B, Walker SA, Mulenga V, Kalolo D, Hawkins N, Sculpher MJ, et al. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. Aids 2008;22:749-57.
  • Sculpher MJ. NICE's 2008 methods guide: sensible consolidation or opportunities missed? Pharmacoeconomics 2008;26:721-4.
  • Sculpher MJ. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008;26:799-806.
  • Soares M, Dumville JC. Critical appraisal of cost-effectiveness and cost-utility studies in health care. Evidence Based Nursing 2008;11(4):99-102. Download from BMJ
  • Soares M, Dumville JC. Economic evaluation of healthcare technologies using primary research. Evidence Based Nursing  2008;11(3):67-71. Download from BMJ
  • Spiby H and the ELSA team. Improving care at the primary/secondary interface: a trial of community-based support in early labour (ELSA). Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO). November 2008. Download from NIHR
  • Tompa E, Culyer AJ, Dolinschi R. Suggestions for a reference case. In: Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:235-44.
  • Tompa E, Culyer AJ, Dolinschi R, (Eds). Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008.
  • Whalley D, Gravelle H, Sibbald B. Impact of the new general medical services contract on general practitioners' job satisfaction and perceptions of quality of care in the UK. British Journal of General Practice 2008;58:8-14.
  • Zarate V, Kind P, Chuang LH. Hispanic valuation of the EQ-5D health states: A social value set for Latin Americans. Value in Health 2008;11(7):1170-77.

2007

  • Asseburg C, Bravo Vergel Y, Palmer S, Fenwick E, de Belder M, Abrams A, Sculpher M. Assessing the effectiveness of primary angioplasty compared to thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart 2007;93:1244-50. Download from BMJ
  • Bansback N, Maetzel A, Drummond MF, Anis A, Marra C, Conway P, Tugwell P, Boers M, Boonen A. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis. The Journal of Rheumatology 2007;34(5):1178-83.
  • Bojke L, Hornby E, Sculpher M; on behalf of the REFLUX Trial Team. A comparison of the cost effectiveness of pharmacotherapy or surgery (Laporoscopic Fundoplication) in the treatment of GORD. Pharmacoeconomics 2007;25(10):829-41.
  • Bravo Vergal Y, Hawkins N, Claxton K, Asseburg C, Palmer S, Woolacoot N, Bruce IN, Sculpher MJ. The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology 2007;46:1729-35. Download from Oxford Journals
  • Bravo Vergel Y, Palmer S, Asseburg C, Fenwick E, De Belder M, Abrams A, Sculpher M. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. Heart 2007;93:1238-43. Download from BMJ
  • Briggs A, Mihaylova B, Sculpher M, et al. The cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 2007;93:1081-6.
  • Caraher M, Carr-Hill R. Taxation, public health and macro-social determinants: ‘sin taxes’ or structured approaches. In: Galea S, Editor. Macrosocial Determinants of Population Health 2007:211-32. 
  • Carr-Hill R. Educational services and nomadic groups. In: Dyer C, editor. The education of nomadic peoples: current issues and future prospects. Berghahn Books;2007.
  • Carr-Hill R, Dixon P. Indicators of equality and diversity: patterns of social difference associated with membership of groups identified by the categories of section 75 of the Northern Ireland Act, 2007:2007. 
  • Castelli A, Dawson D, Gravelle H, Street A. Improving the measurement of health system output growth. Health Economics. 2007;16(10):1091-107.
  • Castelli A, Dawson D, Gravelle H, Jacobs R, Kind P, Loveridge P, Street A, et al. A new approach to measuring health system output growth and productivity National Institute Economic Review 200 (April) 105-117;2007. Download from Sage journals Online
  • Claxton K. OFT,VBP:QED? Health Economics 2007;16:545-58. Download Wiley InterScience
  • Claxton K. The irrelevance of inference: a decision making approach to the stochastic evaluation of health care technologies. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007(0-415-35235-5).
  • Claxton K, Culyer A. Rights, responsibilities and NICE: a rejoinder to Harris. Journal of Medical Ethics 2007;33:462-4. 
  • Colbourn T, Asseburg C, Bojke L, Phillips Z, Claxton K, Ades A, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses  Health Technology Assessment 2007;11(29):1-208.
  • Colbourn T, Asseburg C, Bojke L, Philips Z, Welton N, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: Cost effectiveness and value of information analyses. British Medical Journal 2007;Sept 29;335(7621):655.
  • Cookson R, Dusheiko M, Hardman G. Socio-economic inequality in small area use of elective total hip replacement in the English NHS in 1991 and 2001. Journal of Health Services Research and Policy 2007;12 suppl.
  • Culyer AJ. NICE misconceptions. The Lancet September 11 2007.
  • Culyer AJ. Equity of what in health care? Why the traditional answers don't help policy - and what to do in the future. HealthcarePapers 2007;8(Sp):12-26.
  • Culyer AJ. Need - an instrumental view. In: Ashcroft R, Dawson A, Draper H, McMillan J, editors. Principles of health care ethics, 2nd Edition. Chichester:Wiley;2007;231-238.
  • Culyer AJ. When and how cancer chemotherapy should be privately funded. Oncology Exchange, 2007;6:47.
  • Culyer AJ. Merit goods and the welfare economics of coercion. In: Ver Eecke W,  editor. Anthology regarding merit goods. The unfinished ethical revolution in economic theory. West Lafayette: Purdue University Press;2007;174-200 (reprinted from Public Finance. 1971;26:546-572).
  • Culyer AJ, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Not so… Journal of Health Service Research and Policy 2007;12:190-191. (letter: reply to G Mooney, J Coast, S Jan, D McIntyre, M Ryan and V Wiseman).
  • Culyer AJ. Resource allocation in health care: Alan Williams’ decision maker, the authority and Pareto. In: Mason A, Towse A, editors. The Ideas and Influence of Alan Williams: Be Reasonable -Do it My Way! Oxford: Radcliffe Publishing; 2007. p. 57-74.
  • Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research and Policy 2007;12:56-8. 
  • Davies H, Mannion R, Jacobs R, Powell AE, Marshall MN. Does hospital organisational culture influence hospital performance. Medical Care and Research Review 2007;64(1):66-82.
  • Dawson D, Gravelle H, Jacobs R, Martin S, Smith PC. The effects of expanding choice of provider on waiting times: evidence from a policy experiment. Health Economics 2007;16(2):113-28.
  • Drummond M, Mason A. Costs and cost-effectiveness of cancer therapies: a european perspective. J Clin Oncol 2007;25(2):191-195.
  • Drummond MF. Evidence for coverage decisions: the need for a reality check. Value in Health 2007;10(5):321.
  • Drummond MF. NICE: A nightmare worth having? Health Economics, Policy and Law 2007;2(2):203-8.
  • Dusheiko M, Gravelle H, Yu N, Campbell S. The impact of budgets for gatekeeping physicians on patient satisfaction: evidence from fundholding. Journal of Health Economics 2007;26:242-62.
  • Epstein D. The health related quality of life of patients with acute coronary syndrome: a comparison of early intervention versus conservative management. Revista Espanola de Economia de la Salud 2007;6:380-5.
  • Epstein D, Chalabi Z, Claxton K, Sculpher M. Efficiency, equity and budgetary policies: informing decisions using mathematical programming. Medical Decision Making 2007;27:128-37. Download from Sage Journals Online
  • Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost-effectiveness acceptability curves. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007 (0415-35235-5).
  • Fleurence RL, Iglesias C, Johnson JM. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature. Pharmacoeconomics 2007;25(11):913-33.
  • Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, Herrington SA, Hays RD, Kaplan RM, Ganiats TG, Feeny d, Kind P. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care 2007;45(12):1162-70.
  • Goeree R, Burke N, O'Reilly D, Manca A , Blackhouse G, Tarride JE. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Current Medical Research and Opinion 2007;23(4):671-82. 
  • Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evalutations: stepping forward to optimal decision rules. Health Economics 2007;16:307-317.
  • Gravelle H, Dusheiko M, Sheaff R, Sargent P, Boaden R, Pickard S, Parker S, Roland M. Impact of case managment (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. British Medical Journal 2007;334:31-34. 
  • Gravelle H, Dusheiko M, Sheaff R, Sargent P, Boaden R, Pickard S, et al. Impact of case managment (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. British Medical Journal 2007;334:31.
  • Gravelle H, Hole A. The work hours of general practitioners' workload: survey of English GPs. British Journal of General Practice . 2007;57:96-100.
  • Gravelle H, Siciliani L. Optimal waits and charges in health insurance. February 2007; Department of Economics Discussion Paper 07/02.
  • Griffin SC, Barber JA, Manca A, Sculpher M, Thompson SG, Buxton MJ, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina. British Medical Journal 2007;334(7594):624. Download from BMJ
  • Griffin S, Claxton K, Hawkins N, Sculpher M. Decision models need to be fit for purpose for decision making: response to Caro et al. Value in Health 2007;10(4):319. Download Wiley InterScience
  • Hanratty B, Craig D, Nixon J, Rice S, Christie J, Drummond MF. Are the best available clinical effectiveness data used in economic evaluations of drug therapies? Journal of Health Services Research and Policy 2007;12:(3):138-41
  • Hauck K, Street A. Do targets matter? A comparison of English and Welsh national health priorities. Health Economics 2007;16:275-90.
  • Hicks L, Gibbs I, Weatherly H, Byford S. Managing Children's Homes. Developing effective leadership in small organisations. London: Jessica Kingsley Publications 2007. Details from Jessica Kingsley Publishers
  • Hole AR. A comparison of approaches to estimating confidence intervals for willingness to pay measures. Health Economics 2007;16:827-40.
  • Hole A. Fitting mixed logit models by using maximum simulated likelihood. Stata Journal 2007;7:388-401.
  • Jacobs R, Goddard M. How do performance indicators add up? An examination of composite indicators in public services. Public Money and Management 2007;27(2):103-110.
  • Jacobs R, Goddard M, Smith P. ‌‌‎‌‎ Policy Discussion Briefing, Centre for Health Economics, University of York; 2007.
  • Jacobs R, Goddard M, Smith PC. Are composite indicators a good measure of performance? Laria News, LARIA Newsletter, Local Authorities Research Intelligence Association 2007;83.
  • Jacobs R, Goddard M, Smith PC. Composite measures of performance: should we trust them? Performance Measurement Association Newsletter 2007;6(1):12-14
  • Kennedy A, Reeves D, Bower P, Lee V, Middleton E, Richardson G, et al. The effectiveness and cost effectiveness of a national lay led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. Journal of Epidemiology and Community Health 2007;61:254-61. 
  • Keen J, Deeming C, Moore J, Weatherly H. New labour, equity and public services: a Rawlsian perspective. Policy and Politics. 2007;35(2):197-214.
  • Kind P. Size matters: EQ-5D in transition. Medical Care 2007;45(9):809-11.
  • Manca A, Dumville J, Torgerson DJ, Klaber Moffett JA, Mooney MP, Jackson DA, et al. Randomised trail of two physiotherapy interventions for primary care back and neck pain patients: cost-effectiveness analysis. Rheumatology 2007;46:1495-1501.
  • Manca A, Lambert PC, Sculpher M, Rice N. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelling. Medical Decision Making 2007;27:471-90. Download from Sage Journals Online
  • Marini G. Non-Keynesian effects of fiscal policy: the role of rational expectations, (In Italian). Rivista Italiana di Economia demografia e Statistica 2007.
  • Marini G, Street A. A transactions costs analysis of changing contractual relations in the English NHS. Health Policy. 2007;83(1):17-26.
  • Marini G, Miraldo M, Jacobs R, Goddard M. Foundation Trusts in the NHS: does more freedom make a difference? Health Policy Matters 2007;13:1-8.
  • Martin S, Rice N, Jacobs R, Smith PC. The market for elective surgery: Joint estimation of supply and demand. Journal of Health Economics 2007;26(2):263-285.
  • Mason A. The HealthBASKET Project: documenting the benefit basket and evaluating service costs in Europe. In: Curtis L, ed. Unit Costs of Health and Social Care 2007. Canterbury: University of Kent 2007:15-18. Available at http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007_healthbasket.pdf
  • Mason AR, Carr-Hill R, Myers L. Rapid review of the economic evidence for community engagement and community development approaches in interventions or initiatives seeking to address wider determinants of health. Report and evidence tables. Final report for NICE Community Enagagment project; 2007.  
  • Mason A, Towse A (eds). The ideas and influence of Alan Williams. Be reasonable - do it my way!. New York: Radcliffe Publishing, Oxford. November 2007.
  • Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. The effectiveness and cost-effectiveness of respite for caregivers of frail older people: a systematic review. J Am Geriatr Soc . 2007;55(2):290-9.
  • Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, et al. A systematic review of the effectiveness and cost-effectiveness of different models of community-based care for frail older people and their carers. Health Technology Assessment ; April 2007;11(15):1-176. Download from HTA
  • McCabe C, Claxton K , Tsuchiya A, Raftery J. Assessing the economics challenges posed by orphan drugs: a comment on Drummond et al. International Journal of Technology Assessment in Health Care. 2007;23:397-401.
  • McDaid C, Griffin S, Weatherly H. The Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea-Hypopnoea Syndrome: a Systematic Review and Economic Analysis: Assessment report for the National Institute for Health and Clinical Excellance; September 2007.  
  • Olry de Labry Lima A, Epstein D, Garcia Mochon L, et al. Comparacion de costes y supervivencia en pacientes intervenidos quirurgicamente de cancer colorrectal segun diferentes modelos organizativos. Rev Esp Enfirm Dig. 2007;99(11):643-7.
  • Ossa DF, Briggs A, McIntosh E, Cowell W, Littlewood T, Sculpher M. Recombinant erythropoietin for chemotherapy-related anaemia. Pharmacoeconomics 2007;25:223-37.
  • Preker AS, Xingzhu L, Velenyi EV, Baris E. Public ends, private means: strategic purchasing of health services. Washington D.C: The World Bank; 2007.
  • Robson LS, Clarke J, Cullen K, Bielecky A, Severin C, Bigelow P, Irvin E, Culyer AJ,  Mahood Q. The effectiveness of occupational health and safety management system interventions: A systematic review. Safety Science 2007;45:329-53.
  • Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytical cost-effectiveness models: a suggested framework and example of application. Reprinted in: Culyer A, editor. Health Economics: critical perspectives on the world economy. London: Routledge; 2007 (0415-35235-5).
  • Siciliani L. Optimal contracts for health services in the presence of waiting times and asymmetric information. The BE Journal of Economic Analysis & Policy Contributions 2007;7(1):article 40.
  • Siciliani L, Martin S. An empirical analysis of the impact of choice on waiting times. Health Economics 2007;16(8):763-79.
  • Spilsbury K, Nelson A, Cullum N, Iglesias C, Nixon J, Mason S. Pressure ulcers and their treatment and effects on quality of life: hospital inpatient perspectives. Journal of Advanced Nursing 2007;Mar 57(5):494-504.
  • Street A. Does information technology improve the productivity of the health care system? Revista Espanola de Economia de la Salud. 2007;6(5):282-6. 
  • Street A. Should GPs hold budgets to purchase hospital services? Revista Espanola de Economia de la Salud. 2007;6(2):88-92.
  • Street A. The contribution of ICT to health care system productivity and efficiency: what do we know? Organisation for Economic and Community Development, Paris. March 2007.
  • Street A, Maynard A. Activity Based Financing in England: the Need for continual Refinement of Payment by Results. Health Economics, Policy and Law 2007;2(4):419-27. Download from Cambridge journals‌‌‎
  • Street A, Maynard A. Payment by results (PDF , 41kb)‌‌‎‌‎ : qualified ambition? Health Economics, Policy and Law 2007;2(4):445-8. 
  • Street A, Miraldo M. The impact of the reform of hospital funding in England (PDF , 246kb)‌‌‎‌‎ . Paper presented at: Evaluating Health Policy: New Evidence from administrative Data. University of York 2007.
  • Suresh Punekar Y, Rodriguez-Roisin R, Sculpher M, Jones P, Spencer M. Implications of chronic obstructive pulmonary disease (COPD) on patients health status: a western view Respiratory Medicine 2007;101:661-69. Download from Elsevier
  • Walker S, Palmer S, Sculpher M. The role of NICE technology appraisal in NHS rationing.British Medical Bulletin 2007:1-14.Download from Oxford Journals

2006/2005

2006

  • Ades A, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probablistic sensitivity analysis. Health Economics 2006;15:373-82. Download from Wiley InterScience
  • Ades AE, Sculpher MJ, Sutton A et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006;24:2-29.
  • Baker R, Thompson C, Mannion R. Q-methodology in health economics. Journal of Health Services Research and Policy 2006;11(1):38-45.
  • Boaden R, Dusheiko M, Gravelle H et al. Evercare Evaluation Final Report. National Primary Care Research and Development Centre, University of Manchester; November 2006. Download from NPCRDC 
  • Bravo Vergel Y, Chilcott J et al. ‌‌Compared to endoscopic retrograde cholaniopancreatography for the investigation of biliary tree obstruction. International Journal of Surgery 2006;4(1):12-19.  
  • Bravo Vergel Y, Ferguson B. Difficult commissioning choices. A proposed framework for priority setting and a comparative analysis of rationing policies across West Yorkshire & NEYNL PCTs. Journal of Health Services Research and Policy 2006;11(3):150-155.  
  • Bravo Vergel Y, Sculpher M. Making decisions under uncertainty– The role of probabilistic decision modeling. Family Practice 2006;23(4):391-392.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press 2006. Download from OUP
  • Busse R, Schreyögg J, Smith PC. Editors and editorial for Special issue on hospital case payment systems in Europe. Health Care Management Science 2006;9(3):211-3.
  • Claxton K, Culyer AJ. Wickedness or folly? The ethics of NICE’s decisions. Journal of Medical Ethics 2006;32: 373-377. 
  • Claxton K, Culyer AJ, Sculpher M et al. Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion (Editorial). Health Economics 2006;15:1-4.
  • Claxton K, Sculpher M. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics 2006;24:1055-68.
  • Claxton K, Sculpher M, Fenwick E. Decision making with uncertainty. In: Jones AM, editor. Companion to Health Economics: Edward Elgar; 2006.
  • Cookson R, Dawson D. Hospital Competition and Patient Choice in Publically Funded Health Care. In: Jones AM, editor. The Elgar Companion to Health Economics. Part IV, Chapter 20. Cheltenham: Edward Elgar; 2006.
  • Culyer AJ. NICE's use of cost-effectiveness as an exemplar of a deliberative process. Health Economics, Policy and Law. 2006;1:299-318.
  • Culyer AJ. Paying for performance: neither the end of the beginning nor the beginning of the end. HealthcarePapers 2006;6:34-8.
  • Culyer AJ. Editor.  Health economics: critical perspectives on the world economy, 4 Vols., Abingdon:Routledge, 2006 (Vol. 1, pp. xxvi + 545; Vol. 2, pp,. xi + 450; Vol. 3, pp. viii + 386; Vol. 4, pp. xi + 600).
  • Culyer AJ. Evidence, economics and values in coverage decisions. In Morgan S. Editor. Toward a national pharmaceuticals strategy. Vancouver: Centre for Health Services and Policy Research UBC. 2006;10-11.
  • Culyer AJ. The bogus conflict between efficiency and equity. Health Economics 2006; 15:1155-1158(Editorial).
  • Culyer AJ. Welfarism vs.Extra-Welfarism. Köz-Gazdaság Tudományos Füzetek (Public Economics Science Journal) 2006;1:89-101.
  • Culyer AJ. The nature of the commodity 'health care' and its efficient allocation. In Culyer AJ. Editor.  Health economics: critical perspectives on the world economy, London: Routledge. 2006; 324-346 (reprinted from Oxford Economic Papers, 1971;23: 189-211).
  • Culyer AJ. The normative economics of health care finance and provision. In: Culyer AJ.  Editor. Health economics: critical perspectives on the world economy, London: Routledge, 2006;347-384. (reprinted from A. McGuire, P. Fenn and K. Mayhew (eds.) Providing health care: the economics of alternative systems of finance and delivery, Oxford: Oxford University Press. 1991;34-58).
  • Culyer AJ, Evans RG. Mark Pauly on welfare economics: normative rabbits from positive hats. In: Culyer AJ.  Editor. Health economics: critical perspectives on the world economy, London: Routledge. 2006;148-157 (reprinted from Journal of Health Economics. 1996;15: 243-251).
  • Culyer AJ, Lomas J. Deliberative processes and evidence-informed decision-making in health care – do they work and how might we know?  Evidence and Policy 2006;2: 357-371.
  • Culyer AJ, Saltman R. Privatization – assessing strategies in a central Asian republic. In: Zöllner H, Stoddart G, Selby Smith V. editors Learning to live with health economics, Copenhagen: WHO. 2006; III-95 - III-105 (copyrighted 2003, published 2006).
  • Culyer AJ, Wagstaff A. Equity and equality in health and health care. In: Culyer AJ  Editor: Health economics: critical perspectives on the world economy, London: Routledge. 2006;483-509. (reprinted from Journal of Health Economics. 1993;12:431-457).
  • Dawson D, Jacobs R, Martin S, Smith PC. The impact of patient choice and waiting time on the demand for health care: Results from the London Patient Choice Project. Applied Economics 2006;38:1363-70.
  • Doran T, Fullwood C, Gravelle H et al. Family practice performance in the first year of the UK's new 'pay for performance' scheme: good clinical practice or gaming? New England Journal of Medicine. 2006;355:375-84.
  • Dumville J, Manca A et al. On behalf of the COLPO study group. Cost-effectiveness analysis of open colposuspension versus laparoscopic colposuspension in the treatment of urodynamic stress incontinence. BJOG: An International Journal of Obstetrics and Gynaecology 2006;113:1014-22. Download from Wiley InterScience
  • Dusheiko M, Gravelle H, Jacobs R, Smith PC. The effect of financial incentives on gatekeeping doctors: evidence from a natural experiment. Journal of Health Economics 2006;25(3):449-478.
  • Drummond M, Mason A, Towse A. The desirability and feasibility of economic studies post-launch. European Journal of Health Economics. March 2006 1(7):5-6.
  • Drummond M, Sculpher M, Better analysis for better decisions: has pharmoeconomics come of age? Pharmacoeconomics 2006;24:107-108. 
  • Drummond M, Sculpher M. Better analysis for better decisions: facing up to the challenges. Pharmacoeconomics 2006;24: 1039-42. 
  • English M, Lanata CF, Ngugi I, Smith PC. The District hospital. In: Jamison DT, editor. Disease control priorities in developing countries. Oxford: Oxford University Press; 2006.
  • Epstein D, Mason A. Costs and prices for inpatient care in England: mirror twins or distant cousins? Health Care Management Science 2006 August;9(3):233-42.
  • Fenwick E, Palmer S, Claxton K, Sculpher M, Abrams K, Sutton A. An iterative Bayesian approach to Health Technology Assessment: application to a policy of preoperative optimisation for patients undergoing major elective surgery. Medical Decision Making 2006;26:480-96. Download from Sage Journals Online 
  • Goddard M, Hauck K, Preker A, Smith PC. Priority setting in health - a political economy perspective. Health Economics, Policy and Law 2006;1(1):79-90.
  • Goddard M, Mannion R. Decentralising the NHS: rhetoric, reality and paradox. Journal of Health, Organisation and Managment 2006;20(1):67-73.
  • Gravelle H, Morris S, Sutton M. Economic Studies of equity in the consumption of health care. In: Jones AM, editor. Elgar Companion to Health Economics: Edward Elgar; 2006. p. 193-204. 
  • Gravelle H, Morris S, Sutton M. Economic Studies of equity in the consumption of health care. In: Jones AM, editor. Elgar Companion to Health Economics: Edward Elgar; 2006. p. 193-204. 
  • Gravelle H, Rees R. Microeconomics: Solutions Manual and Workbook. London: Prentice Hall; 2006.
  • Gravelle H, Siciliani L. Is waiting time prioritisation welfare improving? Department of Economics Discussion Paper. 2006;06/13.
  • Griffin S, Bojke L, Main C, Palmer S. Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer. Value in Health. 2006;9(2):123-31. Download from Wiley InterScience
  • Griffin S, Claxton K, Hawkins N, Sculpher M. Probabilistic analysis and computationally expensive models: necessary and required? Value in Health 2006;9(4):244-252. Download from Wiley InterScience
  • Hauck K, Street A. Performance assessment in the context of multiple objectives: a multivariate multilevel analysis. J Health Econ. 2006;25:1029-48.
  • Hollingsworth B, Street A. The market for efficiency analysis of health care organisations. Health Economics. 2006;15:1055-9.
  • Jacobs R, Martin S, Goddard M, Gravelle H, Smith PC. Exploring the determinants of NHS performance ratings: lessons for performance assessment systems. Journal of Health Services Research and Policy. 2006;11(4):211-7.    
  • Jacobs R, Smith PC, Goddard M. The development of composite indicators to measure performance in health care. In: Neely A, editor. Performance Measurement: Theory and Practice. Cambridge: Cambridge University Press; 2006.
  • Jacobs R, Smith PC and Street A. Measuring efficiency in health care: analytic techniques and health policy: Cambridge University Press June 2006.  
  • King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Rchardson G et al. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Wincheste, England: Health Technology Assesment 2006:10(23);iii+146    
  • Main C, Ginnelly L, Griffin S et al. A systematic review of the clinical effectiveness and cost effectiveness of topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer (update). Health Technology Assessment 2006:10(9). 
  • Manca A, Epstein D et al. Randomised trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: a cost-effectiveness analysis. International Journal of Technology Assessment in Health Care 2006;22(1):67-75.
  • Manca A, Willan A. "Lost in translation": accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics. 2006;24(11):1101-19.
  • Mannion R, Marini G, Street A. Demand Management and adminstrative costs under payment by results. Health Policy Matters 2006;12:1-8.
  • Mason J, Mason A. The generalisability of pharmacoeconomic studies: issues and challenges ahead. Pharmacoeconomics 2006; 24(10): 937-945.
  • Mason A, Drummond M, Towse A. Economic post-launch studies: matching the desirable with the feasible. London: Office of Health Economics; 2006 September.
  • Mason A, Smith PC. Regulation and relations between the different participants in the English health care system. Revue Française des Affaires Sociales 2006 September;2:265-84.
  • Mason A, Street A. Publishing outcomes data: is it an effective approach? Journal of Evaluation in Clinical Practice 2006;12(1):37-48.
  • Mason A, Smith P. Le systeme de sante anglais: regulation et papports entre les differents acteurs. Revue Francaise des Affaires Sociales. 2006;16(2/3):265-84.
  • Maynard A, Street A. Seven years of feast, seven years of famine: from boom to bust in the NHS. British Medical Journal 2006;332:906-8. http://bmj.bmjjournals.com/cgi/reprint/332/7546/906 
  • McCabe C, Claxton K, Tsuchiya A, Raftery J. Orphan drugs revisited. Quarterly Journal of Medicine 2006; 99:341-345. Download from Oxford Journals 
  • Nelson E, O'Meara S, Craig D, Iglesias C, Golder S, Dalton J, Claxton K. A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. Health Technology Assessment 2006;10(12):1-238. 
  • Nelson EA, O'Meara S, Golder S, Dalton J, Craig D, Iglesias C. DASIDU Steering Group. Systematic review of antimicrobial treatments for diabetic foot ulcers Diabet Med 2006;Apr;23(4) 348-59. 
  • Nixon J, Nelson EA, Cranny G, Iglesias CP et al. PRESSURE Trial Group. Pressure relieving support surfaces: a randomised evaluation. Health Technology Assessment 2006 Jul;10(22):iii-iv, ix-x, 1-163. 
  • Nixon J, Cranny G, Iglesias C et al. Randomised, controlled trial of alternating pressure mattresses compared with alternating pressure overlays for the prevention of pressure ulcers: PRESSURE (pressure relieving support surfaces) trial. BMJ 2006 Jun 17;332(7555):1413. 
  • Olsen KR, Street A et al. Usikkerhed forbundet med opgorelse af relativ produktivitet i sygehussektoren. Nationalokonomisk Tidsskrift 2006;144:353-61.
  • O'Meara S, Nelson EA, Golder S, Dalton J, Craig D, Iglesias C. DASIDU Steering Group. Systematic review of methods to diagnose infection in foot ulcers in diabetes Diabet Med 2006;Apr;23(4) 341-47.
  • Petherick ES, O'Meara S, Spilsbury K, Iglesias CP et al. Patient acceptability of larval therapy for leg ulcer treatment: a randomised survey to inform the sample size calculation of a randomised trial. BMC Med Res Methodol 2006;Sep 1:6:43.
  • Philips Z, Bojke L, Sculpher M, Claxton K, Golder S. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality of assessment. Pharmacoeconomics 2006;24:355-71.
  • Philips Z, Claxton K, Palmer S, Bojke L, Sculpher M. Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-ST elevation acute coronary syndrome. International Journal of Technology Assessment in Health Care 2006;22(3):379-387. Download from Cambridge Journals.  
  • Richardson G, Hawkins N et al. Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis. International Journal of Technology Assessment in Health Care 2006;22(1):84-89. 
  • Richardson G, Sculpher M et al. Is self-care a cost-effective use of resources? evidence from a randomised trial in inflammatory bowel disease. Journal of Health Services Research and Policy 2006;11(4):225-30. 
  • Scott A, Gravelle H et al. Job satisfaction and quitting intentions: a structural model of British general practitioners British Journal of Industrial Relations 2006;44:519-40. 
  • Sculpher MJ, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making. Health Economics, 2006;15:677-687. Download Wiley InterScience
  • Sculpher M, Drummond MF. Analysis sans frontiers: can we ever make economic evaluations generalisable across jurisdictions? Pharmacoeconomics. 2006;24(11):1087-99.
  • Sheaff R, Schofield J, Mannion R et al. Achieving high performance in health care systems: the impact and influence of organisational arrangements, Studying Health Care Organisations Briefing Paper. London: NHSSDO; 2006.
  • Smith PC. Formula Funding of Public Services. London: Routledge; 2006.
  • Smith PC. The future role of user charges in the National Health Service.  House of Commons Health Committee, NHS Charges: Volume III. London: The Stationery Office; 2006. p. 155-8.
  • Smith PC. User charges for health care: history and prospects. In: Asato J, editor. Charging ahead? Spreading the costs of modern public services. London: Social Market Foundation; 2006.
  • Smith PC. Public packages of health care alongside voluntary insurance. In: Preker A, Scheffler RM, Bassett M, editors. Private voluntary health insurance in development: friend or foe? Washington DC: World Bank; 2006.
  • Smith PC. Quantitative approaches towards assessing organizational performance. In: Boyne GA, editor. Public service performance: perspectives on measurement and management. Cambridge: Cambridge University Press; 2006.
  • Smith PC, Street A. Analysis of secondary school efficiency, Research Report 788. Department for Education and Skills. London 2006. Download here
  • Smith PC, Street A. Concepts and challenges in measuring the performance of health care organisations. In: Jones AM, editor. The Elgar Companion to Health Economics. Cheltenham: Edward Elgar; 2006.
  • Stoltzfus Jost T, Dawson D, den Exter A. The role of competition in health care: a Western European perspective. Journal of Health Politics, Policy and Law 2006;31(3):687-703.
  • Street A. The future of quality measurement in the NHS. Expert Reviews of Pharmacoeconomics and Outcomes Research. 2006;6(3):245-8. Paper available to download here. 
  • Street A. Reforma de la financicion hospitalaria e introduccion de mecanismos de eleccion en el sistema sanitario britanico NHS. Revista Espanola de Economia de la Salud.2006;5(2):97-102. Paper available to download here. English version, Reform of hospital funding and the introduction of patient choice in England . Paper available to download here
  • Street A, Castelli A, Dawson D, Gravelle H. Retos en le medición y valoración de los rendimientos del sistema de salud [Challenges in measuring and valuing health service output]. Revista Española de Economía de la Salud, 2006;5(6)335-360.
  • Street A, Castelli A, Dawson D, Gravelle H. Challenges in measuring and valuing health service output. Revista Espanola de Economi e la Salud 2006;5(6):335-342.
  • Szende A, Culyer AJ. The inequity of informal payments for health care: the case of Hungary. Health Policy. 2006;75:262-271.
  • Urdahl H, Manca A, Sculpher M. Assessing generalisability in model-based economic evaluation studies. A structured review in osteoporosis. Pharmacoeconomics. 2006;24(12):1181-97. Download from Ingenta Connect 
  • Wearden AJ, Riste L, Dowrick C (includes Richardson G). Fatigue intervention by nurses evaluation - The FINE trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome. Biomed Central Medicine. 2006;4(9). Download from BMC 
  • Whalley D, Bojke C, Gravelle H, Sibbald B. Morale of the GP workforce in the light of reform: a national survey of job satisfaction. British Journal of General Practice 2006;56:87-92.
  • Whiting P, Westwood M, Bojke L, Palmer S, Richardson G (includes Sculpher M). Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technology Assessment 2006;10(36).
  • Williams J, Russell I, Durai D (includes Richardson G). What are the clinical outcomes and cost-effectivenss of endoscopy undertaken by nurses when compared with doctors? A multi institution nurse endoscopy trial (MINuET). Health Technology Assessment 2006;10(40). Download from HTA 
  • Woolacott N, Bravo Vergel Y, Hawkins N (includes Palmer S, Claxton K, Sculpher M). Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technology Assessment 2006; 10(31):1-258.
  • Woolacoot N, Hawkins N, Mason A (includes Bravo Vergel Y, Sculpher M). Etanercept and Efalizumab for the treatment of psoriasis: a systematic review. Health Technology Assessment 2006; 10(46):1-252.

2005

  • Anderson GM, Bronskill S, Mustard CA, Culyer AJ et al. Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities. Journal of Clinical Epidemiology 2005;58:757-62.
  • Barbieri M, Drummond M et al. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. Value in Health 2005;8(1):10-23.
  • Boaden R, Dusheiko M, Gravelle H et al. Evercare evaluation interim report: implications for supporting people with long term condistions. National Primary Care Research and Development Centre: University of Manchester; 2005.
  • Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K et al. Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy. 2005;4:201-8. Download from IngentaConnect
  • Castelli A, Dawson D, Gravelle H, Street A. The challenges of measuring government output in the health care sector. Social Policy Review 2005;17:183-202.
  • Claxton K, Cohen JT, Neumann PJ. When is evidence sufficient? A framework for making use of all available information in medical decision making and for deciding whether more is needed. Health Affairs 2005;24. Download from Health Affairs
  • Claxton K, Sculpher M et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Economics 2005;14(4):339-347. Download from Wiley InterScience
  • Collins P, Sibson J, Sihota S, Smith P, Thornton S. To the point: a blueprint for good targets.  Report of the Commission on Targets in the Public Services. London: Social Market Foundation; 2005.
  • Cooke J, Mason A, Drummond MF, Towse AK. Medication management in English National Health Service hospitals. American Journal of Health-System Pharmacy 2005;62:189-195. Download from Pub Med
  • Cookson R, Goddard M, Gravelle H. Regulating health care markets. In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp. 121-147.
  • Cullum N, Spilsbury K, Richardson G. Nurse led care: determining long term effects is harder than measuring short term costs. BMJ 2005;330:682-683. Download from BMJ
  • Culyer AJ. Involving stakeholders in healthcare decisions - the experience of the National Institute for Health and Clinical Excellence (NICE) in England and Wales. Healthcare Quarterly 2005;8:56-60.
  • Culyer AJ. Egészség-gazdaságtan, egészségügyi közgazdászok, és az egészségpolitikai döntéshozás politikája (Health economics, health economists and the politics of policy making). In: Gulácsi L, editor. Egészég-Gazdaságtan. Budapest: Medicina Könyvkiadó Rt; 2005. p. 35-44.
  • Davies HTO, Mannion R, Marshall MN, Jacobs R. Findings from a quantitative analysis of all English NHS acute trusts. In: Mannion R, Davies HTO, Marshall MN, editors. Cultures for performance in health care. Buckingham: Open University Press; 2005.
  • Dawson D, Drummond M, Towse A. European integration and the economics of health care. In: Smith P, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp.248-271.
  • Drummond MF, Manca A, Sculpher M. Increasing the generalisability of economic evaluations: recommendations for the design, analysis and reporting of studies. International Journal of Technology Assessment in Health Care 2005;21(2):165-171.
  • Drummond MF, Sculpher M. Common methodological flaws in economic evaluations. Medical Care 2005;43(7 Suppl):115-14. Download from Pub Med
  • Drummond MF, Sculpher M et al. Methods for the economic evaluation of health care programme. Third edition: Oxford: Oxford University Press; 2005. Download from OUP
  • Elliott R, Sutton M, Gravelle H, Hole A et al. Adjusting the General Medical Services Allocation Formula to Reflect Recruitment and Retention Difficulties: Report to the Department of Health; 2005.
  • Epps H, Ginnelly L, Utley M, Southwood T, Gallivan S, Sculpher M et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technology Assessment 2005;9(39):1-76. 
  • Fleurence RL, Iglesias CP, Torgerson DJ. Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature Osteoporos Int 2006;Jan 17(1) 29-40. Epub 2005 Jun 25.
  • Ginnelly L, Claxton K, Sculpher MJ, Golder S. Using value of information analysis to inform publicly funded research priorities. Applied Health Economics and Health Policy. 2005;4:37-46. Download from IngentaConnect
  • Ginnelly L, Sculpher M et al. Determining the cost effectiveness of a smoke alarm give-away program using data from a randomised controlled trial. European Journal of Public Health 2005;15:448-453. Download from Oxford Journals
  • Godfrey C, Parrott S, Eaton G, Culyer A, McDougall C. Can we model the impact of increased treatment expenditure on the UK drug market. In: Lindgren B, Grossman M, editors. Substance use: individual behaviour, social interactions, markets and politics. Advances in health economics and health services research. Volume 16. New York: Elsevier; 2005. p. 265-84.
  • Hauck K, Shaw R, Smith PC. Formula funding of health purchasers: towards a fairer distribution? In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp. 199-222.
  • Hauck K, Smith P, Goddard M. What to buy? Revisiting priority setting in health care. In: Preker AS, Langenbrunner JC, editors. Spending wisely: buying health services for the poor. Washington DC: World Bank; 2005. p. 61-78.
  • Hawkins N, Sculpher M, Rothman M. Modelling the cost-effectiveness of cardiac interventions: the case of sirolimus-eluting stents. British Journal of Cardiology. 2005;12:AIC83-AIC91. 
  • Hawkins N, Epstein D, Drummond M et al. Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Medical Decision Making 2005;25:493-510. Download from Sage Journals Online
  • Hawkins N, Sculpher M, Epstein D. Cost-effectiveness analysis of treaments for chronic disease: using R to incorporate time dependency of treatment response. Medical Decision Making 2005;25:511-519.
  • Hernandez-Quevedo C, Jones A, Rice N. Reporting bias and heterogeneity in self-assessed health: evidence from the British Household Panel Survey. Ecuity lll working paper 19 Health Econometrics and Data group (HEDG) Working Paper 05/04: York; 2005.
  • Hernandez-Quevedo C (includes Rice N). Socio-economic inequalities in health: a comparative longitudinal analysis using the European Community Household Panel. York: Ecuity lll working paper 31 & Health, Econometrics and Data Group working paper 05/12; 2005.
  • Iglesias C, Birks Y, Nelson EA et al. Quality of life of people with venous leg ulcers: a comparison of the discriminative and responsive characteristics of two generic and a disease specific instruments. Qual Life Res 2005;Sep 14 (7):1705-18.
  • Iglesias CP, Drummond MF, Rovira J, for the Nevalat Project Group. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. International Journal of Technology Assessment in Health Care 2005;21(1):1-14.
  • Jacobs R. Performance Trends in the health service. Figure it out: Statistical Research Bulletin. 2005;5:9-10.
  • Jacobs R, Smith PC, Goddard M. How robust are hospital ranks based on hospital measures. Medical Care 2005; 43(12):1177-84.
  • Jacobs R, Street A. Efficiency measurement in health care: recent developments, current practice and future research. In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp. 148-172.
  • Jones A, Rice N. Using longitudinal data to investigate socioeconomic inequality in health. In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp. 88-120.
  • Kernick D, Mannion R. Developing an evidence base for intermediate care delivered by GPs with a special interest. British Journal of General Practice 2005;55(521):908-910.
  • Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher M, Fox KAA, for the RITA-3 Trial Investigators. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3). Journal of the American College of Cardiology 2005;45(2):221-228. Download from JACC
  • Klaber Moffett JA, Jackson DA (includes Manca A). Randomised trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: outcomes and patients' preference. BMJ 2005;330(7482):75-80. Download from BMJ
  • Levaggi R, Smith PC. Decentralization in health care: lessons from public economics. In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp. 223-247.
  • Lomas J, Culyer AJ, et al. Conceptualizing and combining evidence for health system guidance. Ottawa: Canadian Health Services Research Foundation; 2005.
  • Longworth L, Buxton MJ, Sculpher MJ, Smith DH. Estimating utility data from clinical indicators for patients with stable angina. The European Journal of Health Economics 2005;6:347-353. Download from Pub Med
  • Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Economics 2005;14(5):487-496. Download from Wiley InterScience
  • Manca A, Palmer S. Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Applied Health Economics and Health Policy. 2005;4(2):65-75. Download from Ingenta Connect
  • Manca A, Rice N, Sculpher MJ, Briggs AH. Assessing generalisability by location in trial based cost effectiveness analysis: the use of multilevel models. Health Economics 2005;14(5):471-485. Download from Wiley InterScience
  • Mannion R. Practice based budgeting in the NHS: a review of the evidence. Health Policy Matters 2005;11:1-4.
  • Mannion R. Practice based budgeting in the NHS: lessons from the past; prospects for the future. Report to the Department of Health: Centre for Health Economics, University of York; 2005.
  • Mannion R, Davies H. Taking stock of social capital in the production of health care. Journal of Health Services Research and Policy 2005; 10(3).
  • Mannion R, Davies H, Marshall M. Cultural attributes of 'high' and 'low' performing hospitals. Journal of Health Organization and Management 2005: 19(6): 431-439.
  • Mannion R, Davies H, Marshall M. Impact of star performance ratings in English acute hospital trusts. Journal of Health Services Research and Policy 2005; 10(1):18-24.
  • Mannion R, Goddard M, et al. Decentralisation strategies and provider incentives in health care: evidence from the UK NHS. Applied Health Economics and Health Policy 2005; 4(1):47-54.
  • Mannion R, et al. Alternative futures for health economics: implications for nursing management research. Journal of Nursing Management 2005; 13:377-386.
  • Mannion R, Street A. Payment by Results and demand management: learning from the South Yorkshire laboratory. Report to the Department  of Health: Centre for Health Economics, University of York; 2005.
  • Martin S, Smith PC. Multiple public service performance indicators: towards an integrated statistical approach. Journal of Public Administration, Research and Theory 2005;15(4):599-613.
  • Mason A. Does the English NHS have a 'Health Basket'? European Journal of Health Economics 2005;6(1):SS18-23.
  • Mason A, Smith PC. Description of the Benefit Catalogue. Centre for Health Economics, University of York;  2005.
  • Mason A, Smith P. Description of the Benefit Catalogue, England. Submitted to the European Commission, Sixth Framework Programme Priority, Contract no: FP6 501588; 2005.
  • Mason A, Street A. Publishing outcomes data: is it an effective approach? Journal of Evaluation in Clinical Practice 2005; 12(1):37-48.
  • Mason A, Street A. To publish or not? Experience and evidence about publishing hospital outcomes data: London: Office of Health Economics; 2005.
  • McCabe C, Claxton K, Tsuchiya A. Special status for orphan drugs in health care decision making processes: a wise move? . British Medical Journal. 2005;331:1016-9. Download from BMJ
  • Miller PSJ, Drummond MF, et al. Economic factors assoicated with antithrombotic treaments for stroke prevention in patients with atrial fibrillation. Forthcoming in: European Heart Journal 2005. Download from Oxford Journals
  • Morris S, Sutton M, Gravelle H. Inequity and inequality in the use of health care in England: an empirical investigation. Social Science and Medicine 2005;60(6):1251-66.
  • O'Hagan A, McCabe C (includes Claxton K, Fenwick E, Sculpher M). Incorporation of uncertainty in health economic modelling studies. Pharmacoeconomics 2005;23:529-36.
  • O'Sullivan AK, Thompson D, Drummond MF. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value in Health 2005;8(1):67-79.
  • Palmer S, Sculpher M, Philips Z, Robinson M, Ginnelly L et al. Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIa antagonists in the UK National Health Service? International Journal of Cardiology 2005;100(2):229-240. Download from ScienceDirect
  • Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville JC, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care BMJ 2005;Apr 30;330(7498):1003.
  • Rice N. Department of Health and Social Services' Needs and Effectiveness Evaluation Study: The Kings Fund; 2005.
  • Rice N. The labour supply of nurses in the UK: evidence from the British Household Panel Survey. York: Health, Econometrics and Data Group (HEDG) working paper 05/10; 2005.
  • Richardson G, Gravelle H, Weatherly H et al. Cost-effectiveness of interventions to support self-care: a systematic review. International Journal of Technology Assessment in Health Care. 2005;21(4):423-32. Download from Pub Med
  • Robson L, Clarke J, Cullen K (includes Culyer AJ). The effectiveness of occupational health and safety management systems: a systematic review (full report). Toronto: Institute for Work & Health; 2005.
  • Robson L, Clarke J, Cullen K (includes Culyer AJ). The effectiveness of occupational health and safety management systems: a systematic review (summary). Toronto: Institute for Work & Health; 2005.
  • Roland M, Dusheiko M, Gravelle H, Parker S. Follow up of people aged 65 and over with a history of emergency admissions: analysis of routine admission data. BMJ 2005;330(7486):289-92.
  • Schultz G, Mozingo D, Romanelli M, Claxton K. Wound healing and TIME; new concepts and scientific applications. Wound Repair and Regeneration. 2005;4((Suppl)):S1-S11. Download from Wiley InterScience
  • Sculpher M, Claxton K. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty - when is there sufficient eveidence Value in Health. 2005;8:433-46. Download from Wiley InterScience
  • Sculpher M, Claxton K, Akehurst R. It's just evaluation for decision-making: recent developments in, and challenges for, cost-effectiveness research. In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. p. 8-41.
  • Small N, Mannion R. A hermeneutic science - health economics and habermas. Health Organization and Management 2005; 19(3):219-235.
  • Smith P, Preker AS, Richard S, Light DW. Role of markets and competition. In: Figueras J, Robinson R, Jakubowski E, editors. Purchasing to improve health systems performance. Maidenhead: Open University Press; 2005. p. 102-121.
  • Smith PC. User charges and priority setting in health care: balancing equity and efficiency. Journal of Health Economics 2005;24(5):1018-1029.
  • Smith P. Performance measurement in health care: history, challenges and prospects. Public Money and Management, 2005;25(4):213-220.
  • Smith P, Witter S. Risk pooling and purchasing. In: Preker AS, Langenbrunner JC, editors. Spending wisely: buying health services for the poor. Washington DC: World Bank; 2005.
  • Smith PC, Ginnelly L, Sculpher M. (eds) Health policy and economics. Opportunities and challenges. Maidenhead: Open University Press; 2004.
  • Smith PC, Sculpher M, Ginnelly L. Health economics and health policy: a postscript. In: Smith PC, Ginnelly L, Sculpher M, editors. Health policy and economics: opportunities and challenges: Maidenhead: Open University Press; 2005. pp. 272-279.
  • Smith P, Street A. Measuring the efficiency of public services: the limits of analysis. Journal of the Royal Statistical Society, Series A 2005;168,part 2:401-417.
  • Woolacott N, Hawkins N, Mason A et al (include Sculpher M,). Etanercept and Infliximab for the treatment of psoriasis. Health Technology Assessment 2005.
  • Wilby J, Kainth A, Hawkins N, Epstein D et al (includes Sculpher M, Drummond M). A rapid and systematic review of the clinical effectiveness, tolerability and cost effectiveness of newer drugs for epilepsy in adults. Health Technology Assessment 2005;9(15):1-172. 
  • Willan AR, Lin DY, Manca A. Regression methods for cost-effectiveness analysis with censored data. Statistics in Medicine. 2005;24(1):131-45.
  • Windmeijer F, Gravelle H, Hoonhout P. Waiting lists, waiting times and admissions: an empirical analysis. Health Economics 2005;14(9):971-85.